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ABSTRACT
Microfluidics is the technology of controlling and manipulating fluids at the
microscale. Microfluidic platforms provide precise fluidic control coupled with low
sample volume and an increase in the speed of biochemical reactions. Lab-on-a-chip
platforms are used for detection and quantification of biochemical analytes, capture, and
characterization of various proteins, sensitive analysis of cytokines, and isolation and
detection of extracellular vesicles (EVs).
This study focuses on the development of microfluidic and solid-phase capture
pin platforms for the detection of cytokines, extracellular vesicles, and cell co-culture.
The fabrication processes of the devices, experimental workflows, numerical analysis to
identify optimal design parameters, and reproducibility studies have been discussed.
Layer-by-layer assembly of polyelectrolytes has been developed to functionalize glass
and stainless-steel substrates with biotin for the immobilization of streptavidinconjugated antibodies for selective capture of cytokines or EVs. Microstructure
characterization techniques (SEM, EDX, and fluorescence microscopy) have been
implemented to assess the efficiency of substrate functionalization. A detailed overview
of current methods for purification and analysis of EVs is discussed as well.
Additionally, the dissertation demonstrates the feasibility of a calorimetric
microfluidic immunosensor with an integrated antimony-bismuth (Sb/Bi) thermopile
sensor for the detection of cytokines with picomolar sensitivity. The developed platform
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can be used for the universal detection of both exothermic or endothermic reactions. A
three-dimensional numerical model was developed to define the critical design
parameters that enhance the sensitivity of the platform. Mathematical analyses identified
the optimal combinations of substrate material and dimensions that will maximize the
heat transfer to the sensor.
Lab-on-a-chip cell co-culture platform with integrated pneumatic valve was
designed, numerically characterized, and fabricated. This device enables the reversible
separation of two cell culture chambers and serves as a tool for the effective analysis of
cell-to-cell communication. Intercellular communication is mediated by extracellular
vesicles. A protocol for the functionalization of stainless-steel probe with exosomespecific CD63 antibody was developed. The efficiency of the layer-by-layer deposition
of polyelectrolytes and the effectiveness of biotin and streptavidin covalent boding were
characterized using fluorescent and scanning electron microscopy.

APPROVAL FOR SCHOLARLY DISSEMINATION

The author grants to the Prescott Memorial Library of Louisiana Tech University
the right to reproduce, by appropriate methods, upon request, any or all portions of this
Thesis. It is understood that “proper request” consists of the agreement, on the part of the
requesting party, that said reproduction is for his personal use and that subsequent
reproduction will not occur without written approval of the author of this Thesis. Further,
any portions of the Thesis used in books, papers, and other works must be appropriately
referenced to this Thesis.
Finally, the author of this Thesis reserves the right to publish freely, in the literature,
at any time, any or all portions of this Thesis.

Author _____________________________

Date _____________________________

GS Form 14
(8/10)

DEDICATION
I dedicate this work to my family- my parents, wife, and brother, who always kept faith in
me and constantly supported me.

vi

TABLE OF CONTENTS
ABSTRACT ...................................................................................................................... iii
APPROVAL FOR SCHOLARLY DISSEMINATION ................................................. v
DEDICATION.................................................................................................................. vi
TABLE OF CONTENTS ............................................................................................... vii
LIST OF TABLES ........................................................................................................... xi
LIST OF FIGURES ........................................................................................................ xii
ACKNOWLEDGMENTS .............................................................................................. xx
INTRODUCTION ..................................................................................... 1
1.1

Microfluidic biosensing ...................................................................................... 1

1.2

Extracellular vesicles .......................................................................................... 2

1.3

Rationale ............................................................................................................. 4

1.4

Objectives ......................................................................................................... 10

1.5

Organization of the dissertation ........................................................................ 10

ADVANCES IN MICROFLUIDICS FOR ON-CHIP ISOLATION
AND MOLECULAR PROFILING OF EXOSOMES ................................................ 13
2.1

Background ....................................................................................................... 13

2.2
Exosome biogenesis, molecular cargo, and current state of exosomes-based
research ......................................................................................................................... 16
2.2.1

Biogenesis of exosome ................................................................................. 16

2.2.2

Exosomes: carries of biological information ................................................ 17

2.2.3

Applications and challenges of exosome-based research ............................. 19

2.3

Conventional methods for isolation and detection of exosomes ...................... 21
vii

viii
2.3.1

Conventional isolation techniques ................................................................ 21

2.3.2

Detection and analysis of exosomes ............................................................. 26

2.4

Microfluidics-based methods for exosomes isolation ...................................... 28

2.4.1

The application of the microfluidics platforms in exosome research ........... 28

2.4.2

Microfluidic based exosome isolation techniques ........................................ 28

2.5

Microfluidics-based exosome detection/analysis techniques ........................... 40

2.5.1

Fluorescence ................................................................................................. 40

2.5.2

Colorimetric .................................................................................................. 42

2.5.3

Magnetic based methods ............................................................................... 45

2.5.4

Surface plasmon resonance (SPR) ................................................................ 47

2.5.5

Electrochemical............................................................................................. 49

2.6

Conclusions and discussions ............................................................................. 51

DEVELOPMENT OF ANTIBODY FUNCTIONALIZED PROBE
FOR SELECTIVE PURIFICATION OF EXOSOMES† ............................................ 53
3.1

Background ....................................................................................................... 53

3.2

Materials and methods ...................................................................................... 55

3.2.1

Design and fabrication of the ExoPRIME microprobe ................................. 55

3.2.2

Characterization of the microprobes to validate LbL precursor ................... 56

3.2.3

Confirmation of anti-CD63 antibody immobilization .................................. 57

3.3

Results and discussions ..................................................................................... 58

3.3.1

Structural characterization of the LBL deposition on microprobe surfaces . 58

3.3.2

Validation of the antibody immobilization using fluorescence analysis ...... 60

CALORIMETRIC SANDWICH-TYPE IMMUNOSENSOR FOR
QUANTIFICATION OF TNF-𝛂† .................................................................................. 62
4.1

Background ....................................................................................................... 62

4.2

Materials and methods ...................................................................................... 64

ix
4.2.1

Principle of calorimetric immunosensing ..................................................... 64

4.2.2

Experimental set-up ...................................................................................... 65

4.2.3

Fabrication of immunosensor ....................................................................... 66

4.2.4

Calorimetric immunoassay procedure .......................................................... 68

4.2.5 Numerical analysis of glucose concentration as a function of the
volumetric flow rate .................................................................................................. 69
4.3

Results and discussions ..................................................................................... 70

4.3.1

COMSOL simulations of the glucose concentration profile......................... 70

4.3.2

Standard calibration curve ............................................................................ 72

4.3.3

Stability and reproducibility study ................................................................ 74

4.3.4

TNF-𝛼 concentration in cell culture medium ............................................... 75

4.4

Conclusion ........................................................................................................ 76

NUMERICAL OPTIMIZATION OF KEY DESIGN
PARAMETERS OF A THERMOELECTRIC MICROFLUIDIC SENSOR FOR
ULTRASENSITIVE DETECTION OF BIOCHEMICAL ANALYTES† ................. 77
5.1

Background ....................................................................................................... 77

5.2

Methodology ..................................................................................................... 80

5.2.1

Numerical simulations .................................................................................. 80

5.2.2

Experimental set up for thermoelectric biosensor ........................................ 87

5.3

Results and discussions ..................................................................................... 88

5.3.1

Experimental validation of the numerical model .......................................... 88

5.3.2

Effect of microfluidics channel height .......................................................... 92

5.3.3

Effect of inlets flow rate ratio ....................................................................... 94

5.3.4 The relationship between material thermal properties, heat sink, and
thermoelectric signal ................................................................................................. 96
5.4

Conclusion ...................................................................................................... 101

x
NUMERICAL ANALYSIS OF OPTIMAL DESIGN
PARAMETERS FOR A CELL CO-CULTURE MICROFLUIDIC PLATFORM
WITH AN INTEGRATED PRESSURE-CONTROLLED VALVE† ...................... 102
6.1

Background ..................................................................................................... 102

6.2

Materials and methodology ............................................................................ 104

6.2.1

Device design .............................................................................................. 104

6.2.2

Numerical modeling.................................................................................... 105

6.2.3

Fabrication of cell co-culture microfluidic device ...................................... 108

6.3

Results and discussions ................................................................................... 113

6.3.1 Valve displacement as a function of fluid pressure inside the pressure
chamber ................................................................................................................... 113
6.3.2

Valve displacement as a function of valve thickness and PDMS elasticity 115

6.3.3 Valve deflection as a function of various PDMS base and curing agent
crosslinking ratio ..................................................................................................... 115
6.3.4
6.4

Statistical analysis ....................................................................................... 119
Conclusion ...................................................................................................... 120
CONCLUSIONS AND RECOMMENDATIONS .............................. 121

7.1

Conclusions ..................................................................................................... 121

7.2

Future Work .................................................................................................... 124

APPENDIX .................................................................................................................... 125
BIBLIOGRAPHY ......................................................................................................... 131

LIST OF TABLES
Table 2-1: Summary of a comparative study of existing conventional exosome isolation
techniques ......................................................................................................................... 24
Table 4-1: Microfluidics dimensions and fluid flow model parameters. ......................... 70
Table 6-1: Fluid pressure (mm-H2O) required to deflect the valve 0.5 mm for various
thicknesses and PDMS base to curing agent crosslinking ratio. ..................................... 117
Table A 1: Area under the curve (μV-s) of thermoelectric response (0-2000 pg mL-1
TNF-α) that were used to create the standard calibration curve. .................................... 126
Table A 2: Inter and intra-calorimetric assay variation for devices with 250 pg mL-1
TNF-𝛼. ............................................................................................................................ 127
Table A 3: Global parameters defined for model .......................................................... 128
Table A 4: Parameters used to define the governing equations of the mathematical
model............................................................................................................................... 129
Table A 5: Material properties of water, glass, PDMS, and PMMA obtained from the
COMSOL library. ........................................................................................................... 130

xi

LIST OF FIGURES
Figure 1-1: Schematic of different types of extracellular vesicles. .................................... 3
Figure 1-2: Schematic of the ExoPRIME microprobe as a sensitive bioanalytical
platform for solid-phase purification of exosomes.54 ......................................................... 8
Figure 2-1: Schematic diagram of exosome biogenesis, molecular composition, and
properties........................................................................................................................... 17
Figure 2-2: (A) Schematic of a double-filtration microfluidic device for isolation and
detection of EVs. Based on size-exclusion, particles larger than 200 nm are excluded
by the membrane with a pore size of 200 nm in the sample chamber, whereas particles
smaller than 30 nm pass through the double-filtration device. EVs with a size between
30 and 200 nm are isolated and enriched in the isolation chamber. (B) Image of an
assembled double-filtration device. (C) Schematic of direct ELISA for EV detection
on-chip. The EVs isolated in the double-filtration device is labeled with biotinylated
anti-CD63 antibodies, and then with streptavidin-HRP. The addition of TMB
substrate enables blue color development in the double-filtration device. (D) The
ELISA result is imaged using a smartphone and then transferred to a laptop for data
analysis using ImageJ. Reproduced with permission from Liang et al., 2017 under
Creative Commons Attribution License (CC BY 4.0), Copyright 2017, Springer
Nature. ............................................................................................................................... 29
Figure 2-3: The nano-interfaced microfluidic exosome platform (nano-IMEX). (A)
Schematic of a single-channel PDMS/glass device, with the exploded-view
highlighting the coated PDMS chip containing an array of Y-shaped micro-posts. (B)
The surface of the channel and micro-posts coated with graphene oxide (GO) and
polydopamine (PDA) as a nanostructured interface for the sandwich ELISA of
exosomes with enzymatic fluorescence signal amplification. (C) Surface protein
profiling of COLO-1 cell exosomes (106 μL-1) captured by CD81 mAb. Reproduced
with permission from Zhang et al., 2016 under Creative Commons Attribution NonCommercial 3.0 Unported License, Copyright 2016, Royal Society of Chemistry. ........ 31

xii

xiii
Figure 2-4: A) Schematic illustration of an acoustic-based separation microfluidic
chip for separation of exosomes from whole blood. RBCs, WBCs, and PTLs are
removed by the cell-removal module, and then, exosomes are separated by the
exosome-isolation module. B) An optical image of the integrated acoustofluidic
microfluidic chip. C) The periodic distribution of pressure nodes and the trajectory of
particles with different diameters in each separation module. D, E) Isolation of EVs
from whole blood using the cell-removal module. The images at outlet region when
acoustic waves are (D) off and (E) on. Blood cells are pushed to bottom outlets when
the acoustic field is on. The white stripe in the figure indicates the centerline location
of the CCD image sensor (Scale bar: 500 μm). Reproduced with permission from Wu
et al., 2017. Copyright 2017, National Academy of Sciences. ......................................... 33
Figure 2-5: Operation and layout of integrated nanoDLD chips. (a) Schematic
representation of a DLD pillar array defining the gap size G, pillar pitch λ, and rowto-row shift δ parameters, which determine the geometric angle, θmax, along which
larger particles are deflected. Particle trajectories are illustrated for particles with
diameters DP, above (blue) and below (yellow) the critical diameter DC which
depends on the geometry of the array. (b) Tilt view optical image of the top side of a
22 mm × 30 mm nanoDLD chip, showing the sample inlet and bump outlet via
positions with corresponding directional flow paths for injected sample (red) and
outgoing bumped particle (blue) fluids along with a common bus network. (c) Backlit
optical image of a nanoDLD chip (backside) revealing the through-hole via positions
of the sample inlet (red), bump outlet (blue), and zigzag outlet via bank (yellow). (d)
Optical microscope image highlighting the zoom-in section labeled in (b) with
superimposed flow paths for the sample inlet (red), zigzag mode (yellow), and bump
mode particle (blue) trajectories. NanoDLD arrays are paired to common zigzag
outlet vias or drains, where smaller particles DP < DC exit to the backside of the chip
into a common reservoir and larger particles DP ≥ DC empty into a common bump
outlet bus en route for the bump outlet via. Scale bar = 400 μm. (e) Cross-sectional
chip schematic illustrating the process of sample injection with zigzag and enriched,
bump-particle fluid isolation and collection in common reservoirs on the backside of
the chip from the different via sets. (f) Optical microscope image showing the labeled
zoom-in section of (b) representing the layout of four parallel nanoDLD arrays
relative to the surrounding inlet bus, filters, zigzag outlet vias, and bump outlet bus
features. Scale bar = 300 μm. (g and h) Scanning electron microscopy (SEM) image
zoom-in locations of (f) along the array outlet interface indicating the direction of
larger DP ≥ DC particles bumping at θ ≈ θmax toward the bump outlet bus (g) and
smaller DP < DC particles toward the zigzag outlet via drains (h) as they exit the
array. Scale bars = 5 μm. (i) Tilt view cross-sectional SEM image of a G = 225 nm
array (λ = 400 nm) with a pillar height of 1 μm, typical features of devices used in
this study. Scale bar = 400 nm. Reproduced with permission Smith et al., 2018.
Copyright 2018, Royal Society of Chemistry. .................................................................. 35

xiv
Figure 2-6: (i) Schematic diagram illustrates the ACE (AC electrokinetic) direct
immunoassay procedure. Undiluted whole blood, plasma, or serum sample is added
directly to the chip. A 10- minute application of AC current to the chip affects
dielectrophoretic separation and isolation of target nanoscale extracellular vesicles
(EVs) and other particulates onto the chip electrodes. Unbound material is washed off
the chip with 0.5 X PBS during an additional 10 minutes of AC current. After the
current is stopped, EVs and nucleic acid targets can be analyzed by different methods,
including the addition of fluorescent reporter antibodies and nucleic acid dyes that are
applied to the chip, then incubated for the appropriate times. Following the final wash
step, the chip is ready for direct imaging and analysis of the fluorescent signal. (ii)
Whole blood from a pancreatic cancer patient is glypican-1 and CD63 positive in
ACE Immunoassay. Panels A-C: Whole blood drawn from a patient with PDAC was
applied to an ACE chip (A); application of current caused larger whole blood cells
and particulates to migrate to low-field regions between electrodes (B). A buffer wash
removed most cells and particulates from the chip (C). Panels D-F: Antibodies
against glypican-1 and CD63 were incubated together on the chip, followed by
fluorophore-conjugated secondary antibodies for detection (D, CD63, green; E,
glypican-1, red; F, brightfield image). Panels G-I: As negative controls, primary
antibodies were omitted, and the fluorophore-conjugated secondary antibodies alone
did not label the electrodes (G, green channel; H, red channel; I, bright field image).
Reprinted (adapted) with permission from Lewis et al., 2018. Copyright 2018,
American Chemical Society. ............................................................................................ 39

xv
Figure 2-7: (i) Illustration depicting the scheme of exosomes capture and analysis
procedure using ExoChip. The blood is collected for serum extraction from healthy or
diseased individuals and then exosomes are captured by flowing serum through a
CD63 antibody-coated ExoChip. To visualize the captured exosomes, ExoChip is
processed for membrane-specific dye (DiO) staining. (ii) Experimental strategy for
exosomes immobilization and characterization using ExoChip, The ExoChip is
designed to measure the levels of fluorescently stained exosomes through
fluorescence intensity measurements using microplate readers and allows molecular
characterization of Exosomes contents through a variety of standard assays including
protein analysis (western blots) and mRNA/miRNA analysis (RT-PCR/miRNA open
array). (iii) A working prototype model of PDMS-based ExoChip (three channel)
depicting the flow of serum for exosomes capture in a typical experimental setup. (iv)
Characterization of Exosomes captured using ExoChip, A: Fluorescence microscopy
image of ExoChip channel depicting immobilization of exosomes in native forms
after DiO staining. High magnification (400X) images of control one of the control
chambers (B) and anti-CD63 coated chambers depicting exosomes capture (C). Per
the light-microscopy resolution limits the exosomes as visualized were found to be in
clusters which were also confirmed through confocal microscopy. D: A confocal
microscopic image showing a group of smaller exosomes (depicted as dotted circles)
forming a cluster (bar = 2μm). The native morphology of the exosome vesicles was
revealed following EM analysis. Electron micrograph images showed the absence of
any vesicle immobilizations in control ExoChip (E), whereas the anti-CD63 coated
ExoChip (F) showed the presence of exosomes both in clusters as well as single
vesicles (bar = 500nm). G: A magnified view of a single exosome vesicle as
examined under EM depicting a cluster of exosomes (bar = 100nm). Reprinted
(adapted) with permission from Kanwar et al., 2014. Copyright 2014, Royal Society
of Chemistry...................................................................................................................... 41

xvi
Figure 2-8: Schematic illustration of the proposed aptasensor with HRP accelerated
dopamine polymerization and deposition for exosome detection (ExoAptaSensor).
(A) (I) Exosomes anchored on sulfate/latex beads were captured by biotin-conjugated
aptamer specific to CD63, followed by incubation with streptavidin-conjugated HRP
for colorimetric reaction to convert colorless Dopamine (DA) into brown-black
colored Polydopamine (PDA) in 10 min in Tris buffer (pH 8.5). This oxidation and
polymerization process is accelerated under HRP catalysis and hydrogen peroxide
(H2O2) as the oxidant. (II) Color developed by this aptasensor correlates to exosome
concentrations and allows simple naked eye visualization. (III) Absorbance signals of
the product can also be quantified at 400 nm. (B) Scheme shows the poly-deposition
process of PDA onto surface proteins of exosomes in situ. (C), (D), (E), (F) illustrates
Proof-of-concept study of ExoAptaSensor. (C) Color intensity of PDA deposition at
the target site of HRP where the concentration of H202 varied from 0% to 2%. (D)
Color intensity measured at intervals of 0, 1, 2, 10-, 20-, 30- and 60-min using
ImageJ. (E) Digital images were taken right after color development of exosome
samples in solution using the CD63 ExoAptaSensor. Color intensity was dependent
on exosome concentrations (1010, 108, 106, 103, and 0 (blank) particles, respectively).
(F) Absorbance spectra were obtained at wavelengths from 300 nm to 600 nm, with a
peak at 400 nm correlates with the changes in exosome concentrations. This supports
the ability of the developed colorimetric aptasensor for exosome detection. Reprinted
from Development of a simple, sensitive, and selective colorimetric aptasensor for the
detection of cancer-derived exosomes, Volume 169, Xu et al., 2020a, Page No.
112576, Copyright 2020, with permission from Elsevier. ................................................ 44
Figure 2-9: (a) Operation principle of the coaxial mixer. (b) ELISA analysis against
CD63 and CA19-9 was performed after exosome capture from whole blood. (c) Left:
Image of setup. Right: The pipe is lifted from the magnets showing the NPs captured
at the junctions between the alternate polarization magnets. d Simulation of the
magnetic gradient created between each pair of NdFeB magnets. Nanoparticle
accumulation coincides with the high-intensity nodes. The tubing is represented with
solid and dashed blue lines. Reproduced with permission from Sancho-Albero et al.,
2020 under Creative Commons Attribution License (CC BY 4.0), Copyright 2020,
Springer Nature. ................................................................................................................ 47
Figure 2-10: Schematic view of SPRi in combination with antibody microarray to
capture and detect exosomes in the cell culture supernatant. Antibodies specific to
exosome transmembrane proteins were printed on the gilded gold chip. The optical
path from the laser passes through the coupling prism at a fixed angle of incidence,
and the reflection is recorded by a CCD camera. Upon injection of sample into the
flow cell, exosomes can be captured by antibodies on the chip, resulting in changes in
the refractive index and therefore changes in the reflection intensities, which are
monitored by the CCD camera. Reproduced with permission from Zhu et al., 2014
(article link: https://pubs.acs.org/doi/10.1021/ac5023056), Copyright 2014, American
Chemical Society. Any future use of this content is subjected to permission from ACS
Publications. ...................................................................................................................... 48

xvii
Figure 2-11: (i) Schematics of complete detachable microfluidic analysis system with
electrochemical aptasensor (DeMEA) for sequential analysis of cancerous exosomes.
(ii) Clinical plasma samples analysis to quantify the exosomes derived from MCF-7
cancer cells using the developed DeMEA and ELISA. The results obtained from the
DeMEA and ELISA are represented in (a) bar graph, (b) scatter graph. All
measurements were carried out in triplicate, and error bars correspond to standard
deviations from independent measurements (n = 3). Reprinted from Detachable
microfluidic device implemented with electrochemical aptasensor (DeMEA) for
sequential analysis of cancerous exosomes, Volume 169, Kashefi-Kheyrabadi et al.,
2020, Page No. 112622, Copyright 2020, with permission from Elsevier. ...................... 51
Figure 3-1: ExoPRIME probe functionalization workflow.54 .......................................... 56
Figure 3-2: SEM micrographs of the tips (left panels) and stem (middle panels) of
polished plain needles (A, B) and LBL-coated microneedles (D, E), showing
successful and efficient deposition polyelectrolyte bilayers. The right panels show the
corresponding EDX spectra of plain (C) and LBL-coated (F) microneedles.54 ............... 59
Figure 3-3: Fluorescent images confirming successful LBL assembly and Biotin
immobilization on microneedles: (A) LbL+Biotin-EDC+Streptavidin+Biotin-FITC;
(B) LbL+Biotin-FITC; (C) Biotin-FITC. (D) ImageJ analysis of the CTPF of A, B,
C.54 .................................................................................................................................... 61
Figure 4-1: Principle of calorimetric immunosensing. The amount of heat released
during the enzymatic reaction between the glucose oxidase conjugated detection
antibody and glucose is proportional to the concentration of TNF-α in the biological
sample 83............................................................................................................................ 65
Figure 4-2: Schematic diagram of the setup for calorimetric immunosensing of TNFα 83. .................................................................................................................................... 66
Figure 4-3: (A) Microfluidic device for calorimetric detection of TNF-α. (B) Image of
thin-film Sb/Bi thermopile sensor. The reaction zone was located above the measuring
junctions 83. ....................................................................................................................... 67
Figure 4-4: Glucose concentration profile along the width of the microchannel. Inlet
1 velocity is 6.7×10-4 m s-1. Inlet 2 flow velocity is: (A) 6.7×10-4 m s-1; (B) 1.67 ×10-4
m s-1; (C) 0.84 ×10-4 m s-1. (D) Graphical representation of glucose concentration
along the width of the microchannel for various velocity flow ratios 83. ......................... 71
Figure 4-5: (A) Standard calibration curve for calorimetric microfluidic
immunosensor. (B) Thermopile voltage output for various concentrations of synthetic
TNF-α.83 ............................................................................................................................ 73
Figure 4-6: (A) Stability study for the developed calorimetric biosensor. (B) The
concentration of TNF-𝛼 in the cell culture medium of lipopolysaccharide treated and
non-treated human astrocytes were measured using conventional microplate-based
ELISA and calorimetric immunosensor (n=4).83 .............................................................. 75

xviii
Figure 5-1: (a) Schematic of the microfluidic device with an integrated
thermoelectric sensor. Hydrodynamically focused glucose introduced through Inlet 2
flows directly above the measuring junctions of the sensor. (b) Schematic of the
aluminum holder. The reference junctions of the thermopile are in contact with the
aluminum block that serves as a heat sink while the measuring junctions of the
thermopile and the reaction zone are position directly above the air gap. 230................... 82
Figure 5-2: Glucose concentration profiles and locations of the bolus injection
relative to the reaction zone at 0, 40, 80, and 120 seconds. The fluid flow rates for
inlet 1 and inlet 2 were 100µL min-1 and 25µL min-1, respectively.230............................. 89
Figure 5-3: A comparison between the numerical and experimental voltage signal of
the thermopile sensor. The upper and lower channel walls of the device were
fabricated out of glass. The fluid flow rates for inlet 1 and inlet 2 were 100µL min-1
and 25µL min-1, respectively.230........................................................................................ 90
Figure 5-4: Mathematical simulations of thermopile voltage output as a function of
microfluidic channel height (Tc). The upper and lower channel walls of the device
were fabricated out of glass. The fluid flow rates for inlet 1 and inlet 2 were 100µL
min-1 and 25µL min-1, respectively.230 .............................................................................. 94
Figure 5-5: Numerical analysis of the effect of inlet flow rate ratio on the thermopile
voltage output. The channel height was 100µm and the upper and lower channel walls
were formed out of glass.230 .............................................................................................. 95
Figure 5-6: Mathematical simulation of the temperature outputs at the (a) reference
junctions and (b) measuring junctions of the thermopile in the presence and absence
of aluminum heat sink. Channel height 100µm, upper and lower channel wall
fabricates out of glass.230................................................................................................... 97
Figure 5-7: Numerical simulation of voltage output as a function of material type.
The channel height was 50µm. The fluid flow rates for inlet 1 and inlet 2 were 100µL
min-1 and 25µL min-1, respectively. (a) Thermopile reference junctions at ambient
temperature. (b) Thermopile reference junctions in contact with a heat sink.230 .............. 99
Figure 5-8: Effect of substrate material on voltage output obtained using the 2-D
model and neglecting the lateral heat dissipation. .......................................................... 100
Figure 6-1: Design of microfluidics cell co-culture platform. Pressure controlled
valve separates the cell chambers (A). Upon release of the pressure, the valve moved
to a vertical position and allows the exchange of signaling molecules between the cell
lines.241 ............................................................................................................................ 105
Figure 6-2: (a) Schematic of the components of the cell co-culture device. (A)
hydraulic pressure chamber, (B) PDMS valve, (C) channel wall, and (D) glass; (b)
Schematic and dimensions of hydraulic valve.241 ........................................................... 106

xix
Figure 6-3: PDMS microfluidic cell co-culture device fabricated using replica
molding.241 ...................................................................................................................... 109
Figure 6-4: Cell-co culture device fabricated by a photolithography technique using
PDMS. (A) Design of the chrome-plated photomask, (B) Pattern transferred to silicon
wafer after completion of the photolithography process, (C) Solidified PDMS
fabricated chips. .............................................................................................................. 111
Figure 6-5: Microfluidic cell co-culture device fabricated using stereolithography
method: (A) SolidWorks design for the top (yellow) and bottom (black) channel
walls, (B) & (C) Images of the fabricated lower channel wall of the device with
integrated supports to prevent bending. .......................................................................... 112
Figure 6-6: Valve displacement in the vertical direction as a function of (a) pressure
exerted by the fluid inside the pressure chamber, and (b) thickness of the valve.
Simulations were performed for the 10:1 elastomer base to crosslinker ratio.241 ........... 114
Figure 6-7: Pressure (mm-H2O) required for 0.5mm valve deflection as a function of
valve thicknesses and PDMS elasticity.241...................................................................... 115
Figure 6-8: Simulation of the effect of PDMS elasticity in valve defections. Analyses
were performed for a device that has a 30 mm pressure chamber height, 0.5 mm thick
valve, and 10:1, 20:1, 40:1, and 50:1 crosslinking ratio of PDMS base and curing
agent.241 ........................................................................................................................... 116
Figure 6-9: Surface plot of the values of the fluid pressure (mm-H2O), valve
thickness, and PDMS elasticity ratio that ensures 0.5 mm displacement of the
valve.241 ........................................................................................................................... 119
Figure A 1: Temperature distribution profile at the outer surface of the lower channel
wall 0, 60, and 240 seconds after the introduction of the substrate. The channel height
is 50μm and the upper and lower channel walls are fabricated from glass. (i)
Reference junctions not in contact with a heat sink; (ii) reference junctions in contact
with the aluminum heat sink. .......................................................................................... 125

ACKNOWLEDGMENTS
First and foremost, I would love to express my gratitude to Allah- the Almighty,
and most merciful - for giving me the guidance, strength, and the ability to carry out this
work. I was fortunate enough to be supervised by an amazing mentor, Dr. Gergana
Nestorova, who guided and cooperated with me not only in my research but also
motivated me while in distress. It would not be an exaggeration to say that she is the kind
of advisor that a doctoral candidate always dreams of. I would like to express my deepest
gratitude to her for being so kind to me, without which I could never complete this work
successfully.
I would like to thank my advisory committee members for their careful review
and valuable advice. My cordial regards to Dr. Reis who has been a co-author in several
peer-reviewed articles for his amazing guidance and cooperation. I want to thank my
current and former lab partners- Daniel Nwokwu, Hope Hutson, Deriesha Gaines, and
Thomas Holland who were very supportive as colleagues and cordial as friends.
Furthermore, I thank Mr. Davis for teaching me the operating principles of various
instruments at IFM. I am very grateful to my friends, Md Tanbin Hasan Mondal, and
Mohammed Al-Evan Chowdhury for helping me to learn the fabrication processes and
get educated in operating numerical modeling software.
I am forever grateful to my parents and my brother whose love and prayers have
always been a major source of my strength and motivation. The accomplishment will not

xx

xxi
be fulfilled if I do not mention my lovely caring wife, who continuously motivated me
even when I was not sure about finishing this journey. Without her support and care
every day, it would be an unfinished story.
Finally, I want to thank the Bangladeshi student community in Ruston, who made
me feel at home, loved, and cared for me like a family which has been an absolute
blessing for me at a place that is a thousand miles away from home.

INTRODUCTION

1.1

Microfluidic biosensing

Biosensors are defined as the analytical devices or units that involve the
immobilization of a biological or chemical recognition element on a physiochemical
transducer to detect or quantify analytes 1. Microfluidics immunosensors offer multiple
advantages that include increased reaction rate, decreased time for incubation of the
reactants, and reduced reagents and samples consumption. Miniaturization and
integration of the multiple assay components allow automation, precise control of the
fluid velocity, increased reproducibility, and the possibility for high-throughput analysis
2

. With these advantages, the development of microfluidic biosensors provides the ability

to integrate chemical and biological components into a single platform that opens the
door for biosensing applications that provide portability, real-time detection,
unprecedented accuracies, and simultaneous analysis of different analytes in a single onchip device. Recent years have witnessed significant progress in the development of
more efficient detection technologies for lab-on-a-chip immunoassays that provide
increased sensitivity and specificity for point-of-care application. A wide range of
detection technologies has been integrated with lab-on-a-chip biosensors for the
quantification of analytes in biological and chemical samples. The optimal detection
method provides high sensitivity coupled with low power consumption, simple
1
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fabrication, and minimal sample preparation 3. Fluorescence, chemiluminescence, and
electrochemiluminescence techniques provide detection sensitivities in the ng-pg mL-1
range 4. Reported limits of detection in fluorescence immunosensors include 0.7 ng ml-1
for troponin T 5, 0.1pg mL-1 for prostate-specific antigen (PSA) 6 and 0.05 ng mL-1 for
okadaic acid 7. Electrochemical immunosensors offer superior sensitivity and versatility
in the choice of substrate. High-sensitive detection of PSA was achieved at 3.3 pg mL-1 8
and the reported limit of detection for alpha-fetoprotein was 2 pg mL-1 9. Paper-based
immunoassay provides a fast and cost-effective technique for detection and quantification
of molecular species. Some of the applications of paper-based immunoassays include
HIV 10 and influenza virus detection 11. While these detection methods are wellestablished, each of these techniques has limitations. Major drawbacks of the
electrochemical detection technology are the effect of external factors such as pH,
temperature, and ionic concentration on the performance of the assay e.g. handling and
analyses of complex solutions 12. Disadvantages of fluorescent immunosensors are the
requirement for high-efficiency optical filters and detectors that presents an engineering
challenge in the miniaturization of the excitation and detection apparatus without
significantly compromising detection sensitivity 13. Although paper-based microfluidics
offers enormous potential for point-of-care devices, the overall sensitivity of the device
needs to be improved 14.
1.2

Extracellular vesicles

Intercellular communication mediates the physiological development of tissues
and organs 15. This occurs via direct interaction of one cell with the neighboring one or
via secretion of biological or chemical substances that mediate specific responses 16.
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Since their discovery over three decades ago, extracellular vesicles (EV) are attracting the
interest of the scientific community due to their important role in cell-to-cell
communication and their potential as a source of biomarkers 17,18,19. EVs contain
complex cargos that include proteins, lipids, nucleic acids, and miRNAs that are released
by the cells into a variety of bodily fluids, e.g., blood, urine, saliva, synovial fluid, and
cerebrospinal fluid 20,21. According to their biogenesis and structures, EVs are categorized
as apoptotic bodies, microvesicles, and exosomes (Figure 1-1).

Figure 1-1: Schematic of different types of extracellular vesicles.
Exosomes are the smallest type of EVs (40 – 160 nm) and are released by
endosomal multivesicular bodies (MVBs) via endocytic pathways 22. Exosomes play a
major role in cell-to-cell communication via the transfer of their cargo and influence the
response of the recipient cell. Exosomal membranes are enriched in tetraspanins (CD63,
CD9, and CD81) and the cargo (miRNA, protein) are used as biomarkers for disease
diagnostics and prediction of therapeutic response 23. Isolation and genetic analysis of
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antigen-specific vesicles from the total exosome population are crucial for understanding
the state of degenerating tissues that are otherwise inaccessible in the central nervous
system 24. Astrocyte-neuron communication is the key regulator of overall brain function,
so exosomes from these cells serve as important indicators of the progression of
neurological diseases in brain tissues 25. The proteomic and nucleic acid cargo contained
within the exosomes acts as a signal carrier that influences the physiological response of
the recipient cells. They are considered a promising source of biomarkers for disease
diagnosis including cancer, diabetic cardiomyopathy, arthritis, asthma, and
neurodegeneration since their biological cargo reflects the pathophysiological condition
of the host cell 16, 26, 27, 28. Exosomes also hold massive potential as therapeutic agents due
to their ability to protect nucleic acid and proteins from degradation. The explosion of
new research data validates their immense potential in the areas of liquid biopsy and
targeted therapeutics delivery 20, 21, 22, 29.
1.3

Rationale

Tumor necrosis factor-α (TNF-α) is a cytokine that is associated with a range of
pathological conditions and its biological levels are commonly measured for research and
diagnostics purposes 30. Increased serum level of TNF-α is measured in Alzheimer’s
disease 31, cancer 32, and inflammatory response 33. Considering the clinical importance
of TNF-α, its accurate and sensitive quantification in biological fluids is important for
disease monitoring, diagnostics, and drug development. TNF-α is commonly measured
using conventional immunoassays. However, tests performed in microtiter plates are
time-consuming, suffer from intra- and inter-assay variations, and require multiple wash
steps that are difficult to adapt in a high throughput setting. The sophisticated, expensive,
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and bulky equipment and large sample volumes that are required per assay render
traditional enzyme-linked immunosorbent technology unreliable for time-sensitive
measurement of TNF-α in clinical settings 34. A number of biosensors for detection of
TNF-𝛼 have been developed that provide increased sensitivity, reduced sample volume
and decreased cost per sample. Optical detection, such as florescence microscopy, has
been employed for rapid quantification of TNF-α (45 pg mL-1) in serum 35 and cell
culture medium (20 pg mL-1 ) 36. TNF-α was quantified using electrochemical
immunosensing in human saliva (3.1 pg ml-1) 37, human serum (10pg mL-1) 38, and
electrochemical impedance spectroscopy (1pg mL-1) in non-diluted human serum
samples 39. The current lab-on-a-chip detection methods for TNF-α offer sensitivity, but
they generally require sophisticated and bulky detection systems that cannot be readily
incorporated into an integrated total analysis system. Calorimetric microfluidic systems
with integrated miniaturized thermopile sensors are employed to measure small quantities
of heat for biosensing applications. Since most bio-chemical reactions are accompanied
by a change of heat, microfluidic calorimetry is employed in a wide range of applications.
This detection method is universal and allows the measurements of reactions that are not
compatible with other detection methods such as studies of single-cell metabolism 40.
Thermopile sensors were used to monitor the metabolic rate of bacteria 41, cell culture for
toxicity assessment 42, DNA sequencing 43, detection of enthalpy change caused by
enzymatic reactions 44, quantification of DNA damage 42, and assessment of binding
affinity 45. Therefore, a calorimetric sandwich-type microfluidic immunoassay is
developed and implemented for the detection and quantification of TNF-α using a thinfilm antimony-bismuth thermopile that is attached to the lower channel wall of the
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device. The sensor converts the temperature difference caused by the enzymatic reaction
between glucose and glucose oxidase conjugated TNF-α detection antibody into an
electric signal that is recorded by a nanovolt meter. The calorimetric technique can be
used for the analysis of any kind of reaction that generates a measurable amount of heat.
The microfluidic device requires less sample volume, the method does not need any
complex sample preparation, and fabrication of expendable chips can result in reduced
cross-contamination. Microfluidic calorimetry offers detection of label-free biochemical
components by immobilizing the enzyme, DNA, or antibodies within a reaction area 42,43.
As mentioned in section 1.2, exosomes hold massive potential as therapeutic
agents, disease biomarkers, and drug delivery tools, therefore, selective capture and
purification of exosomes carry great interest. All the current technologies of exosome
isolation have limitations that prevent the application of exosomes in a clinical or
laboratory setting, and therefore prevent the study of exosomes from reaching their full
potential 46. Multiple technologies that improve exosomal isolation have been developed,
and the process has rapidly evolved in recent years. Methods of exosome isolation
currently include ultracentrifugation and filtration, size-exclusion techniques, polymer
precipitation, immunoaffinity, and microfluidics 47. Most ultracentrifugation methods are
coupled with filtration to increase total exosomal yield. This method can vary slightly
from protocol to protocol but includes a series of ultracentrifugation steps at high speeds
with long assay times. Ultracentrifugation generally has a low exosomal yield (< 5%),
meaning that less than 5% of the total sample volume recovered in the final product
consists of microvesicles and high rates of contamination due to tearing of the
membranes and clumping 48. A size-exclusion approach yields a purer exosome
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subpopulation compared to ultracentrifugation because microvesicles are very small in
size and the solid phase of the chromatography column removes cell lysate or other
sources of contamination 49. Although size-exclusion chromatography has a simpler
protocol and involves more readily available equipment, it still has a low total yield (<
8%) and is a nonspecific capture method 47. Polymer precipitation is the most common
approach to exosome isolation. It requires little equipment, encompasses a simple
protocol, and provides a relatively high total product yield (> 25%). This method,
however, can only process a very small sample volume, has a long assay time (8 h or
more), and carries the risk of compromising the structural integrity of the microvesicles
isolated 50. Immunoaffinity techniques largely involve the use of antibody-coated beads
which are specific to the membrane proteins embedded in the lipid membrane of the
exosomes and the approach can be used in almost any biological media. This method is
highly specific and has a high total yield and purity at the time of capture (>99%).
However, immunoaffinity capture-based techniques require additional exosomal
enrichment step that is usually done by ultracentrifugation, polymer-precipitation, or sizeexclusion chromatography 47. Microfluidics strategies for exosome isolation integrate on
a lab-on-a-chip platform already established purification methods including sizeexclusion chromatography 51 and immunoaffinity 52. The main goals of these techniques
are target-specific capture while reducing contamination rates and increasing the total
product yield. This method, however, has no standardized protocol and yields a variety of
experimental results 53.
To overcome various difficulties observed in traditional exosome purification
technologies, a novel microprobe-based method has been developed for noninvasive and
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site-specific exosome purification and genetic analysis. Stainless-steel exosome capture
pins (130 µm × 4 mm) are functionalized with an anti-CD63 antibody that selectively
binds to the corresponding tetraspanin (Figure 1-2). The technology is expected to have
an important impact in the field of extracellular vesicle research as this immunocapture
approach will enable selective purification of exosomes and will allow direct integration
with standard systems for genomic analysis. A microprobe-based approach to exosome
isolation eliminates the need for large, expensive equipment in the protocol and creates
an affordable platform that is widely accessible by scientific and medical facilities.
Microneedles are noninvasive and are therefore a preferred method of laboratory testing
from a medical standpoint. This approach will reduce the lengthy, multistep procedures
which currently encompass exosome isolation down to a single step.

Figure 1-2: Schematic of the ExoPRIME microprobe as a sensitive bioanalytical
platform for solid-phase purification of exosomes.54
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Another important rationale of this work is to develop a microfluidic technology
for the analysis of cell-to-cell and cell-extracellular matrix interactions is an important
topic in biomedical engineering research. While conventional cell co-culture approaches,
such as transwell-type co-culture plates, are successfully used for functional analysis of
cell-to-cell communications, this technology does not permit a controlled exchange of
fluids between two cell culture chambers 55. Lab-on-a-chip platforms enable a real-time,
on-chip analysis of the interaction between cells and their microenvironments.
Microfluidics provides flexibility in the device design and better control of the
experimental conditions that facilitate drug discovery studies 56. Cell co-culture
microdevices with an integrated valve enable precise control of the exchange of
biochemical factors while minimizing sample variability and enhancing the sensitivity of
the analysis 57. Therefore, an innovative microfluidic cell co-culture platform with a
pneumatically controlled valve has been reported. Additionally, various design
parameters have been optimized using a numerical model developed in COMSOL
Multiphysics to observe the valve deflection and the isolation of the two chambers. The
proposed microfluidics platform offers a promising new tool for the assessment and
characterization of the complex interaction of different cell types.
1.4

Objectives

The main objectives of the study are summarized below:
•

Experimental and numerical characterization of a microfluidic platform
for thermoelectric immunodetection of biochemical analytes.

•

Development of a cell co-culture microfluidic platform with and without a
pneumatically controlled valve. Efforts are focused on fabrication using
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3D printing and soft-lithography, and mathematical modeling to identify
optimal design parameters.
•

Demonstrate the feasibility of exosomes specific anti-CD63 antibody on
the surface of stainless-steel microprobes for purification of exosomes.
1.5

Organization of the dissertation

The studies are organized in this dissertation as five standalone articles (four of
them are already published as peer-reviewed journals and conference papers). Chapters 2
through 6 each represent one article, and chapter 7 is the overall summary of the findings
and suggestions for future studies.
A literature review on the advancements in exosome isolation and analysis
methods from various biological fluids is reported in chapter 2. The advantages and
disadvantages of existing methods for isolation and detection methods of the exosomes
and other extracellular vesicles are summarized. The applications of microfluidics in
exosome isolation and analysis, their respective advantages and disadvantages have been
presented. This chapter is currently under preparation for submission as a review article.
In chapter 3, the preparation and functionalization of stainless-steel microprobes
with CD63 antibody is described for isolation of exosome subpopulations that express the
same surface marker. The efficiency of the probe functionalization with polyelectrolytes
and biotin was assessed using FESEM and fluorescence microscopy. This work is
included in a journal article published in Talanta (Elsevier, IF: 6.057).
In chapter 4, a lab-on-a-chip thermoelectric immunoassay is reported for sensitive
quantification of the inflammatory cytokine TNF-α with picomolar sensitivity. The
feasibility of the platform was validated via accurate measurement of the concentration of
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TNF- α in astrocytes cell culture media. The immunoassay was performed in a
microfluidic device with an integrated antimony/bismuth thermopile sensor. This novel
immunosensing platform presented excellent accuracy along with other certain
advantages of the microfluidic platform when compared to the commercially available
absorbance-based ELISA method. This chapter was published in Biosensors and
Bioelectronics (Elsevier, IF: 10.618).
A three-dimensional numerical model of the microfluidic calorimetric
immunosensor presented in chapter 4 is developed and analyzed to determine the effects
of the operational parameters, geometry, and choice of the substrate materials on device
sensitivity. This study is reported in chapter 5 along with the detailed numerical modeling
obtained using COMSOL Multiphysics software. This numerical model was published in
the Journal of Thermal Science and Engineering Applications (ASME, IF: 1.47).
Chapter 6 discusses the design and parameters optimization of a microfluidic coculture platform with an integrated pneumatic valve. This study includes the fabrication
of microfluidic devices using three different microfabrication processes: replica molding,
photolithography, and stereolithography. A 2-D numerical analysis is performed to
identify the optimal design parameters to study the impacts of the height of the pressure
chamber, the thickness of the valve, and the elasticity of the PDMS elastomer on the
efficiency of the valve actuation. These results have been published in the Conference
proceedings of the International Mechanical Engineering Congress and Exposition
(ASME IMECE 2020).
Chapter 7 summarizes the important conclusions and recommendations for future
studies.

ADVANCES IN MICROFLUIDICS FOR ON-CHIP ISOLATION AND
MOLECULAR PROFILING OF EXOSOMES

2.1

Background

Intercellular communication mediates the physiological development of tissues
and organs 15. This occurs via direct interaction of the cell with the neighboring one or
via secretion of biological or chemical substances that mediate specific responses 16.
Since their discovery over three decades ago, EVs are attracting the interest of the
scientific community due to their important role in cell-to-cell communication and their
potential as a source of biomarkers 17,19,58. EVs contain complex cargos that include
proteins, lipids, nucleic acids, and miRNAs that are released by the cells into a variety of
biological fluids, including blood, urine, saliva, synovial fluid, and cerebrospinal fluid
20,59

. According to their biogenesis and structures, EVs are categorized as apoptotic

bodies, microvesicles, and exosomes (Figure 1-1). Exosomes are the smallest type of
EVs (40 – 160 nm) and are released by endosomal multivesicular bodies (MVBs) via
endocytic pathways 22. The proteomic and nucleic acid cargo contained within the
exosomes acts as a signal carrier that fuses with and influences the physiological
response of the recipient cells. They are considered a promising source of biomarkers for
disease diagnosis including cancer, diabetic cardiomyopathy, arthritis, asthma, and
neurodegeneration since their biological cargo reflects the pathophysiological condition

12

13
of the host cell 16,26,28,60. Exosomes also hold massive potential as therapeutic agents as
well due to their ability to protect nucleic acid and proteins from degradation. The
explosion of new research data validates their immense potential in the areas of liquid
biopsy and targeted therapeutics delivery 20,22,29,59.
The protein contents in exosomes include transmembrane proteins, lysosomederived membrane proteins, E-cadherin, membrane-associated proteins, GTPases, heat
shock proteins, lipid-related proteins, phospholipases, tetraspanins, and proteins
associated with the multivesicular body (MVs) biogenesis 61–64. Multiple studies suggest
that proteomic analysis of exosomes provides critical information that can assist early
detection and diagnosis of cancer, metabolic diseases, neurological disorders, and
immune regulation 65. Therefore, isolation of pure exosomal subpopulation from a
biological fluid is crucially important to determine their pathophysiological functions.
Current methods for exosomes isolation include ultracentrifugation 66, size-exclusion
chromatography 67, ultrafiltration 68, polymer-based precipitation 69, and immunoaffinity
capture 70. This review provides a detailed discussion of the barriers in conventional
exosome isolation and detection techniques and the most recent advancements and
challenges in microfluidics-based methods for purification and on-chip detection of
exosomes.
Several detection techniques have been employed for the analysis, size
characterization, and molecular profiling of different exosomal subpopulations. Flow
cytometry 71, Scanning electron microscopy (SEM) 72, transmission electron microscopy
(TEM) 73, dynamic light scattering (DLS) 74, atomic force microscopy (AFM) 75, enzymelinked immunosorbent assay (ELISA) 76, and nanoparticle tracking analysis (NTA) 77 are
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commonly used in both clinical and research settings. The drawbacks of this method are
the need to use expensive and complex equipment that limits the access of many labs to
this type of analysis 16.
To address the challenges of conventional technologies for the isolation and
detection of exosomes, microfluidic platforms offer a promising approach for the
efficient purification and molecular characterization of EVs. Microfluidic technology
requires low sample volume and minimal consumption of expensive reagents. The
dimensions of the microchip provide a high surface-to-volume ratio that enhances the
reaction rate within the microchannels. Moreover, the lab-on-a-chip methods provide a
fast, simple, highly sensitive, and cost-effective way for the isolation of exosomes
compared to the conventional commercially available technologies 16,78. Due to these
tremendous characteristics, microfluidics has been implemented in cell analysis 79,80,
point-of-care diagnostics 81,82, sensitive detection of biochemical analytes 83, and
molecular analysis 84. The preparation of a pure exosomal population is crucial for the
development of point-of-care tests for disease diagnosis and novel therapeutic agents
65,85–87

88

. In microfluidic devices, exosomes are mainly isolated based on the particle size

, immunoaffinity 89, or electrical charge 90, and the efficacy of separation can be

increased by applying external hydrodynamic force 91, acoustic field 92, or electrical field
93

.
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2.2

Exosome biogenesis, molecular cargo, and current state of exosomes-based
research

2.2.1

Biogenesis of exosome
The exosomes were described initially as clusters of endosome-derived

nanovesicles that are released into the extracellular microenvironment 94. The biogenesis
of exosomes starts in early endosomes (Figure 2-1). Matured or late-endosomes move to
the cytoplasm, change their tube-like shape into spherical, and form the multivesicular
bodies (MVBs). Inward budding results in the progressive accumulation of intraluminal
vesicles (ILVs) inside the MVP. The development of the multivesicular endosomes can
follow either of the following pathways 16.
•

MVBs fuse with lysosomes and degrade their content.

•

MVBs fuse with the plasma membrane and release their content in the
extracellular space.
For the first type, the MVBs are being hydrolyzed by the lysosomes. In the case

of the second instance, the MVBs tend to fuse with the plasma membrane and release
ILVs into the microenvironment. Once the ILVs are released into the extracellular space,
they are called exosomes 95. Studies indicated that the formation of ILVs and the process
of exosome release are mediated by tetraspanins (CD9, CD63, CD81), glycan
modification, and Rab guanosine triphosphatases (RAB 27A, RAB 27B, RAB 31, and
RAB 11) 16,29,96,97. The complex underlying biology of exosomes formation and what
factors govern the transition of the MVBs to the exocytic pathway or the degradative
pathway remain to be further characterized 98.
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2.2.2

Exosomes: carries of biological information
Exosomes contain a diverse cargo that includes proteins, DNA, mRNA, non-

coding RNA, tRNA, and lipids 16. The proteins are derived from various intracellular
components such as MVBs, nuclei, mitochondria, cytosol, plasma membranes, and Golgi
bodies 29. Vesiclepedia and ExoCarta are databases used to catalog the protein content of
exosomes from many organisms and cell types 99. The main drawback of these databases
is the lack of verification as all the information is recorded by the users. Therefore,
several researchers have reviewed the protein contents of exosomes 100,101. To summarize
the literature, the proteins are mainly characterized as exosomal marker proteins
(TSG101, HSP90β, HSC70, Alix), common proteins (CD9, CD63, CD81, CD82), and
specific proteins (EpCAM) 16,47. The exosomal marker proteins are found in the
exosomes regardless of the cell origin due to their formation and regulation via the
proteins carried by the endosomal sorting complexes required for transport (ESCRT)
102,103

. The common proteins (also known as the transmembrane proteins) belong to the

tetraspanin family and are enriched with exosomes 104. However, the tetraspanin proteins
are also available in MVs and apoptotic bodies 105. The specific protein, such as the
epithelial cell adhesion molecule (EpCAM), is found in cancer-derived exosomes.
EpCAM is a glycoprotein that expediates the homo-typical adhesion of cells. EpCAM
has been identified in pseudo-stratified, transitional, and simple epithelia on the
basolateral surfaces and recognized as a cargo protein in exosomes 106. EpCAM is
quantified to a certain degree in the normal epithelia of many organs and is highly
overquantified in various types of carcinomas 107. In addition to the protein contents,
miRNA, mRNA, tRNA, nucleic acids, DNA, and lipids have also been identified in
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exosomes 108–114. The lipid contents in exosomes include saturated fatty acids,
cholesterol, sphingomyelin, and phosphatidylserine 115.

Figure 2-1: Schematic diagram of exosome biogenesis, molecular composition, and
properties.
Exosomes play a crucial role in intercellular communication that is based on the
exchange of genetic information between the donor and the recipient cells

94

. The

genomic and proteomic expression levels of the exosomal cargo are altered in various
pathophysiological conditions. Exosomes alter the tumor microenvironments of tumors
by facilitating metastasis and influence the response of the cells of the immune system
116

. In addition to that, exosomes also take part in central nervous system communications

in various pathophysiological conditions such as glioblastoma 117. The composition of the
vesicle membrane reflects the pathological condition of the parent cell and can be used as
a biomarker for the detection of malignancies 96. Over the last decade, there has been a
growing interest in exosomes in the area of biotechnology. Exosomes hold huge potential
as disease biomarkers for clinical diagnosis provided by the ease of access from a variety
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of biological fluids and their cell-specificity. These EVs are potential tools for drug
delivery due to their specificity and low immunogenic potential 94.
2.2.3

Applications and challenges of exosome-based research
Exosomes contribute to the development of several pathological processes

suggesting that they have the potential to serve as diagnostic biomarkers and therapeutic
agents. Urinary exosomes contain cargoes such as miRNA29, mRNA, Aquaporin-2, and
antimicrobial urinary tract proteins that can be used as biomarkers to diagnose renal
fibrosis, diabetes mellitus, and urinary tract infection 118–120. Exosomes released by
uteroplacental (maternal-placental) contain has-miRNA-210 that can perform early
detection of preeclampsia 121. In this study, the authors found that the level of hsa-miR210 was significantly higher in preeclampsia placentas, which could cause a minor
increase of exosomal and a high elevation of Ago-bound miR-210 in circulation. Another
study found the potential of the exosomal amyloid peptides and tau proteins as the
biomarkers for Alzheimer’s patients 122. Tetraspanins expressed on the surface of
exosomes released from tumor sites (CD9, CD63) can be used for the prognosis of the
survival rate 123. Exosomes reflect the physiological state of the donor cell and therefore
demonstrate superior target sensitivity and specificity compared to other categories of
biomarkers such a genomic and proteomic expression biomarkers 22. Exosomes are
promising nanocarriers for targeted drug delivery. Their cell-derived lipid bilayer is
biocompatible and can deliver endogenous biological cargo to the recipient cell 124. Since
exosomes are derived from the patient’s cells, they are not recognized and degraded by
the immune system and have low toxicity 125. Exosome-based drug delivery systems
have been used across the blood-brain barrier for the treatment of neurogenerative
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disorders 126. Chen et al. studied the effect of bone marrow mesenchymal stem cell
(BMSC)-derived exosomes carrying miRNA-125b on ischemia-reperfusion injury (I/R)
rats, where the researchers examined that the BMSC-derived exosomes carrying miRNA125b protect against myocardial I/R by targeting SIRT7 and potentially can serve as a
therapeutic method for myocardial I/R 91. Another study revealed that mesenchymal
stromal cells inhibit in vitro tumor growth when they were primed with paclitaxel (PTX),
and later released in exosomes 127. Kim et al. reported that the macrophage-derived
exosomes loaded with potent anticancer agent paclitaxel (PTX) represent a novel
nanoformulation (exoPTX) that showed superior anticancer efficiency in a mouse model
of pulmonary metastases. The researchers developed and optimized an expression of
PTX-loaded exosomes combined with aminoethylanisamide-polyethylene glycol (AAPEG) to target the sigma receptor- a biomarker that is overexpressed by lung cancer cells.
The AA-PEG-vectorized exosomes primed with PTX (AA-PEG-exoPTX) attained a high
loading capacity, intensified ability to accumulate in cancer cells upon systemic
administration, and improved therapeutic outcomes, which offers a potentially novel drug
delivery platform for anticancer therapeutics for pulmonary metastasis 128.
The most important requirement for the development of exosome-based
diagnostic and drug delivery platforms is the development of rapid and specific exosome
isolation techniques. It is often very difficult to apply a high-throughput process for their
separation due to the inconsistencies in content and cell-specific uniqueness of exosomes.
Current methods for exosomes separation do not produce a pure exosomal population and
are often contaminated with other types of extracellular vesicles, proteins, and cellular
debris. Additionally, they do not yield a population of exosomes that carry the same
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surface marker, a requirement that is crucial to explore their full potential as clinical
biomarkers. For example, the cerebrospinal fluid contains exosomes that carry vital
information about the function of the central nervous system, and methods for
purification that can noninvasively access and preconcentrate the vesicles would provide
a major drive for the diagnosis of neurological disorders. Therefore, the development of a
highly selective method for exosome separation is crucial for exosome-based research.
2.3

Conventional methods for isolation and detection of exosomes

The main methods for exosomes isolation are based on the properties of the
vesicles such as size, protein surface markers, and density. To focus more on the recent
development of microfluidic technologies, this review will briefly summarize each
conventional method for exosomes characterization and their drawbacks in the following
sections.
2.3.1

Conventional isolation techniques

2.3.1.1

Ultracentrifugation
The centrifugation technique separates biomolecules according to their size

difference. Ultracentrifugation and differential centrifugation are considered the gold
standard for exosome isolation 65. Centrifugation at lower speed is applied to isolate
larger vesicles and cellular debris (< 20,000 g) that is followed by ultracentrifugation (>
100,000 g) to separate exosomes from protein contaminants 20. The ultracentrifugation
method does not require sample pre-treatment and is the most common method in
exosomes research accounting for 56% of all published papers in the literature 129,130.
The major drawbacks of this method are the requirement for special centrifugation
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instruments coupled with low purity, poor repeatability, and lengthy protocols 20,22.
Differential centrifugation has low exosome isolation efficiency (5 - 25%) and purity
caused by contamination with protein aggregates 131.
2.3.1.2

Immunoaffinity-capture
Immunoaffinity-based separation of exosomes is based on the expression of a

specific surface marker on the surface of the vesicles. An antibody immobilized on the
surface of a platform is used for the selective capture of the exosomal subpopulation via
antigen-antibody interaction. The most commonly used markers are the tetraspanins CD9,
CD63, CD81, and CD82. Some recent accomplishments in exosome separation from
bodily fluids are achieved by the immunoaffinity-based isolation method are presented in
the literature 132–134. The immunoaffinity-based isolation technique offers a high yield and
purity, time-effectiveness and does not require special equipment 135. Zarovni et al. have
shown that antibody-based separation of exosomes provides 10 – 15 times better yield
compared to the ultracentrifugation method. Isolation kits based on immunoaffinity-based
separation are commercially available (e.g., ExoFACSTM) 136. However, this isolation
technique is viable for exosome subpopulations with recognized biomarkers and cannot
be used for all types of exosomes. Moreover, expensive reagents, and maintaining strict
pH conditions also interfere with the application of this approach for large-scale exosome
isolation 16.
2.3.1.3

Ultrafiltration
Ultrafiltration is one of the widely used size-based exosome isolation techniques

that rely on particle size and molecular weight 137. In this method, suspended solids and
solutes of high molecular weight are trapped by the membrane while lower molecular
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weight solutes and water pass through. Studies indicate that the ultrafiltration method is
often combined with the ultracentrifugation method to obtain high purity of exosomes
138,139

. To describe the combined process more precisely, ultrafiltration is implemented to

isolate large cells and EVs followed by an ultracentrifugation process to purify exosomes
from proteins. The ultrafiltration separation technique has been employed to separate
highly pure exosomes from urine samples 140. Several other research groups have
explored commercially available ultrafiltration-based exosome isolation kits (e.g. Amicon
filter, and ExoMir) for successful isolation of exosomes from protein contaminants 20,131.
This size-based method carries multiple advantages over the widely used
ultracentrifugation process such as a fast and simple process and no stipulation of using
specific equipment. However, clogging and trapping of exosomes in the filters result in a
low yield 137. Although this problem can be resolved to some extent by washing the filters
after each step, this can be time-consuming. Furthermore, the force exerted on the sample
to propel through the filters may cause the deformation of the larger exosomes that results
in distorting the isolation process 141.
2.3.1.4

Size-exclusion chromatography (SEC)
This size-based isolation technique is based on a conventional chromatography

approach with a specially selected porous stationary phase which is often combined with
ultracentrifugation or filtration methods for isolating exosomes from bodily fluids or
proteins. Unlike the ultrafiltration method, SEC uses commercially available sizeexclusion columns for the isolation technique. Before flowing through the column, large
EVs and cell debris are separated by either ultrafiltration or ultracentrifugation.
Commercially available size-exclusion columns are employed to isolate exosomes 67,142.
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One of the biggest advantages of SEC is its ability to sustain biological activity and
integrity due to the means of gravitational force being used for isolation. However,
ultracentrifugation is commonly used with SEC to obtain better purity of the isolate
143,144

. There are a variety of commercially available SEC-based kits that provide high

purity, but their expensive price limits their application in the wide-scale separation
process.
2.3.1.5

Polymer-based precipitation
The precipitation-based exosome isolation technique is carried out by using a

precipitation reagent to modify the solubility of exosomes. These reagents create
exosome-containing residues for retrieval of exosomes using membrane filtration or
standard centrifugation (~ 10,000 g). This is a relatively easy, instrument-free method
where hydrophobicity of the exosomal membrane is utilized. Moreover, the polymerbased precipitation method provides a highly reproducible technique for high vesicles
and RNA yield 46. Various commercial precipitation-based exosomes separation kits are
ae available on the market (e.g., Exo-spinTM, Exo-QuickTM, Total Exosome Isolation
Reagent by InvitrogenTM, Exo-S, Exo-Q, and miRCURYTM). These commercial kits
provide very good efficacy for low volume of the biofluids from serum, plasma, and
cerebrospinal fluids (CSF) 145. The critical drawback of this approach is that the
precipitation reagents enable exosomal aggregation and co-precipitation of proteins 20.
Other disadvantages of precipitation-based separation include the high cost of the
consumables, low specificity, and poor yield.
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Table 2-1: Summary of a comparative study of existing conventional exosome isolation
techniques

Isolation

Isolation

technique

principle

Parameters

Time

Ultracentrifugatio

Density-

n

based

*

Yield

*

Advantages

Disadvantages

Ref.

Purity

**

The gold

Time-consuming (~5

standard, highly

h); low yield and

pure

purity; large sample

65,146

volume required

Immunoaffinity-

Affinity-

capture

based

**

**

***

Highly specific

Expensive; strict pH

and pure

condition; constrained

133,134

use

Size-exclusion

Size and

chromatography

molecular

**

**

**

Simple, rapid,

Poor specificity;

high yield

scaling problems

Simple and user-

Expensive; low

friendly

specificity; poor

67,142,144

weight

Polymer-based

Surface

precipitation

charge-

**

***

**

based

47,145

purity; scaling
problems

Ultrafiltration

Molecular

**

**

**

Rapid, simple,

Clogging; low yield,

weight and

no specific

low specificity, time-

size-based

instrument

consuming

138–141

Appraisal parameters are categorized by ***, **, and * imply very good, moderate, and
poor performances respectively.
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2.3.2

Detection and analysis of exosomes

2.3.2.1

Flow cytometry
Flow cytometry is a widely used conventional detection method for detecting a

large amount of EVs. The technique enables high throughput multiplex analysis of
exosomal surface markers 147. This detection technique is based on laser-based detection
of fluorescence-labeled exosomes. A dedicated detector captures the resulting signal that
is comprised of the emitted fluorescence and scattered light. Despite its advantages, the
use of flow cytometry in exosome analysis is often avoided due to its low sensitivity and
resolution 148. To overcome the difficulties of this method, scientists have implemented a
special type of flow cytometry, known as fluorescence-activated cell sorting (FACS),
where the suspended exosomes are separated according to their specific and distinct
fluorescence features 149. Recent studies in the literature have shown the enactment of
FACS for exosome analysis 150–152. However, FACS requires sophisticated instruments
which often may not be readily available and thus halts its ability to be implemented in
lab-like low-resourceful settings 22.
2.3.2.2

ELISA
Enzyme-linked immunosorbent assay (ELISA) is a technique that uses labeled

antibodies to measure the protein of interest in a biological sample. In a traditional
format, the exosomes adhere to the surface of a 96-well plate. A primary antibody that is
specific to the exosomal surface protein marker is introduced into the well to form an
antigen-antibody complex with the exosomes. A secondary antibody labeled with an
enzyme binds with the primary antibody and an enzyme-generated colorimetric signal is
measured by a plate reader 153. ELISA is one of the most commonly used techniques for
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the detection of EVs due to the requirement of a very low sample volume 154. In recent
years, digital ELISA kits have emerged which offer immaculate sensitivity for a low
volume of samples 155,156.
2.3.2.3

Tunable resistive pulse sensing (TRPS)
Tunable resistive pulse sensing (TRPS) is based on the principle that the

movement of the non-conductive components in an electrolyte solution can cause a
change in the electrical impedance vis-à-vis particle concentration, surface charge, and
size of the particles 157. This phenomenon is also known as the Coulter principle. TRPS
offers great accuracy in determining the size, concentration, and surface charge of
exosomes by determining the change in impedance or using a resistive pulse signal 158,159.
2.3.2.4

Dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA)
Both DLS and NTA approaches are based on the Brownian motion principle to

measure the size and concentration of the nanoparticles 160. While the DLS method
analyzes the relative change in the intensity of the scattered light induced by the
Brownian motion of the bulk samples of suspended nanoparticles e.g., exosomes, NTA
implements the Stokes-Einstein equation to calculate the hydrodynamic diameter of each
nano component 161,162. Due to their capabilities to discern nanoparticles of various sizes
ranging from 1 to 1000 nm, both DLS and NTA have been widely used for the detection
and analysis of exosomes. However, low throughput and inaccuracy of the results often
create issues for heterogeneous samples that are prone to aggregation 160.
All the isolation and detection techniques of the exosomes discussed above have
been successfully implemented for the detection and characterization of exosomes. There
are a few drawbacks of these conventional techniques which include the requirements of
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sophisticated instruments, implementation of separate techniques for isolation and
analysis, the isolation of non-specific exosomes, and EVs 163. All these difficulties have
made it challenging to implement these isolation and detection techniques as diagnostic
tools in clinical settings.
2.4
2.4.1

Microfluidics-based methods for exosomes isolation

The application of the microfluidics platforms in exosome research
Recent years have witnessed the emergence of microfluidics for capturing and

analysis of the EVs including exosomes from various bodily fluids by successfully
resolving the issues associated with the conventional methods. Microfluidics offers
multiple advantages over the conventional techniques that include low sample volume for
precious samples, the ability for multiplexing, cost-effectiveness, and the integration of
sensors that provide precise control over the fluid 164,165. Lab-on-a-chip technology has a
high potential for clinical applications due to throughput, reduced cross-contamination,
and combined technique for an exosomes isolation-detection process 166. The following
sections will summarize currently available microfluidics-based approaches for exosome
isolation and detection.
2.4.2

Microfluidic based exosome isolation techniques

2.4.2.1

Filtration
In microfluidic technology, filtration is one of the commonly used reagent-free

methods for the separation of exosomes from various biofluids. Filtration is performed by
using nanoporous membranes or nanopillar arrays incorporated in a microfluidic device
78

. Membrane-based filtration of extracellular vesicles from a blood sample using
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microscale technology was first successfully demonstrated by Davies et al. Pressuredriven and electrophoresis-driven filtration were performed using an in situ prepared
nanoporous membrane using a mouse’s whole blood sample. This approach demonstrated
an isolation capacity of 3 μL and 240 μL, respectively, with a recovery yield of ~1.5% in
both cases 167. However, the microfluidic device clogged after the extraction of 4 μL
filtrate, which was resolved by the electrophoresis method that provides higher purity and
better throughput. Electrophoresis-driven filtration was also implemented by Cho et al. to
isolate extracellular vesicles from mouse plasma. The authors developed a process to
separate proteins using a dialysis membrane which also trapped the EVs on the
membrane surface. This process provided a better throughput, higher yield, and fewer
protein impurities (~ 84% compared to ultracentrifugation) 93. With the development of
microfluidics in exosome research, scientists have implemented an advanced doublefiltration technique to isolate exosomes from urinary samples where the membrane with a
larger pore size (~ 200 nm) was used to retain large EVs and protein samples whereas
small EVs were trapped on the second membrane surface (pore size ~ 30 nm) while
smaller proteins passed through 168 (Figure 2-2). This double filtration approach was also
implemented on a “lab-on-a-disc” Exodisc method, which produced high throughput and
recovery yield as well as lowered the protein impurities (~ 96% compared to
ultracentrifugation) 88. Pillar-based filtration is another method of isolating exosomes that
incorporates one or more arrays of pillar-based structures to migrate larger molecules and
isolate exosomes using a reversed flow. This technique has been implemented for the
isolation of exosomes from biofluids with fast processing time (~ 10 min) and good yield
(~ 60%) 169,170. However, the recovery yield gradually decreases with larger sample
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volumes which are considered as the saturation effect 78. Moreover, this process requires
off-chip downstream analysis to isolate exosomes with greater efficiency and purity.

Figure 2-2: (A) Schematic of a double-filtration microfluidic device for isolation and
detection of EVs. Based on size-exclusion, particles larger than 200 nm are
excluded by the membrane with a pore size of 200 nm in the sample chamber,
whereas particles smaller than 30 nm pass through the double-filtration
device. EVs with a size between 30 and 200 nm are isolated and enriched in
the isolation chamber. (B) Image of an assembled double-filtration device.
(C) Schematic of direct ELISA for EV detection on-chip. The EVs isolated in
the double-filtration device is labeled with biotinylated anti-CD63 antibodies,
and then with streptavidin-HRP. The addition of TMB substrate enables blue
color development in the double-filtration device. (D) The ELISA result is
imaged using a smartphone and then transferred to a laptop for data analysis
using ImageJ. Reproduced with permission from Liang et al., 2017 under
Creative Commons Attribution License (CC BY 4.0), Copyright 2017,
Springer Nature.
2.4.2.2

Immunoaffinity-based separation
Efficient isolation of exosomes in microfluidic devices using an immunoaffinity-

based approach requires the selection of antibodies. It is the most common microfluidicsbased exosome isolation method. One of the earlier works represented an easy and fast
immunoaffinity-based isolation of exosomes using anti-CD63 antibody from serum using
a microfluidic device with herringbone groves 171. Later, Kanwar et al. used the same
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antibody functionalized microfluidic chip for isolation of exosomes from serum sample
and proposed the name of the kit as “ExoChip”. ExoChip was fabricated from PDMS and
the surfaces were modified with anti CD63 antibody for successful isolation of exosomes
89

. To perform ultrasensitive isolation and analysis of exosomes, a 3D nanostructure

(comprised of graphene oxide and polydopamine) coated microfluidic device was used to
capture exosomes from plasma samples using an anti-CD81 antibody (Figure 2-3) 172.
Results implemented that the addition of the nanointerface increased the exosome
isolation efficiency with reasonable yield compared to the other existing methods. A
more recent study performed by Zhang et al. presented a herringbone mixer-based
microfluidic chip that can directly separate exosomes from plasma using an
immunoaffinity-based approach. This method enabled successful capture of pancreatic
cancer-specific, Glypican-1 expressing exosome subpopulation with good yield while
avoiding non-specific bindings 173. However, immunoaffinity-based capture requires
careful selection of antibody, and the purity of the isolated exosomes needs improvement.
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Figure 2-3: The nano-interfaced microfluidic exosome platform (nano-IMEX). (A)
Schematic of a single-channel PDMS/glass device, with the exploded-view
highlighting the coated PDMS chip containing an array of Y-shaped microposts. (B) The surface of the channel and micro-posts coated with graphene
oxide (GO) and polydopamine (PDA) as a nanostructured interface for the
sandwich ELISA of exosomes with enzymatic fluorescence signal
amplification. (C) Surface protein profiling of COLO-1 cell exosomes
(106 μL-1) captured by CD81 mAb. Reproduced with permission from Zhang
et al., 2016 under Creative Commons Attribution Non-Commercial 3.0
Unported License, Copyright 2016, Royal Society of Chemistry.
2.4.2.3

Acoustic fluid-based isolation
Acoustofluidics is the combination of microfluidics and acoustics methods for the

separation of various bioparticles depending upon their size differences, density,
membrane composition, and acoustic properties. This isolation method offers both a
reagent-free and contact-free approach. In this process, continuous acoustic streaming
enables acoustic forces of various magnitudes based on the particle sizes that act on the
same plane as the microsensor. The performance of acoustofluidic devices is based on the
principle that particles in an acoustic field experience radiation forces that alienate them
from the pressure antinodes, and as a result, pushing the particles toward the pressure
nodes along with a counteracting Stokes drag force 165. The drag force is proportional to
the radius while the acoustic radiation force is proportional to the volume. Hence, larger
particles (e.g., blood cells) get deflected from their paths more than smaller particles
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(e.g., exosomes) subjected to acoustic waves. Acoustofluidics has been implemented
successfully by different research groups to separate cells, particles, and nanoscale
vesicles from biological fluids 92,174. Wu et al. have developed a novel acoustofluidic
platform for the successful isolation of exosomes directly from an undiluted human blood
sample. The integrated device had two sequential surface acoustic wave-based
microfluidic modules- one to remove cells, and the other for the isolation of exosomes
(Figure 2-4). Using this novel method, the authors achieved about 98% purity in the
isolated exosomes from just 100 μL of the blood sample with high yield in 25 minutes,
which was faster than the conventional centrifugation approach 92. In one of the more
recent studies, Z. Wang et al. implemented acoustofluidics to successfully separate
traumatic brain injury (TBI) related exosomes from blood plasma. The study indicated
that TBI-induced exosome samples contained an increased amount of glial fibrillary
acidic protein (GFAP). To evaluate that the isolated exosomes were indicative of TBI
diagnosis, pre-TBI and post-TBI samples were labeled with fluorescent dyes and neuron
intake studies were performed which concluded that the TBI-induced samples had higher
intake rates compared to the healthy samples. More researchers are getting involved
during recent years in using acoustic-fluid based exosome isolation techniques for cancer
detection, liquid biopsy, and brain injury due to its capability of isolating highly pure
exosomes in a very short time by using very low volume of samples 176.
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Figure 2-4: A) Schematic illustration of an acoustic-based separation microfluidic chip
for separation of exosomes from whole blood. RBCs, WBCs, and PTLs are
removed by the cell-removal module, and then, exosomes are separated by
the exosome-isolation module. B) An optical image of the integrated
acoustofluidic microfluidic chip. C) The periodic distribution of pressure
nodes and the trajectory of particles with different diameters in each
separation module. D, E) Isolation of EVs from whole blood using the cellremoval module. The images at outlet region when acoustic waves are (D) off
and (E) on. Blood cells are pushed to bottom outlets when the acoustic field
is on. The white stripe in the figure indicates the centerline location of the
CCD image sensor (Scale bar: 500 μm). Reproduced with permission from
Wu et al., 2017. Copyright 2017, National Academy of Sciences.
2.4.2.4

Deterministic lateral displacement (DLD)
The deterministic lateral displacement (DLD) method acts upon the principle that

the flow path of the particles larger or smaller than the critical size is altered while
providing a natural flow path for the rest of the particles 177. This continuous-flow
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separation technique allows the particles larger than the critical size to displace laterally
while the smaller particles flow through the fluid streamline. For the DLD approach, a
gradient of nano-pillar arrays having specific critical sizes for particle separation is
arranged within the microfluidic channels with proper spacing between the pillars. DLD
has been implemented for separating cells, particles, and bioparticles from various fluids
and biofluids with very high resolution (~ 10 nm) 178–180. An array of pillars with a 2 µm
gap between each one was fabricated and implemented for the separation of 51 nm
diameter nanoparticles, which was found to be effective for the isolation of particles
ranging from 51 nm to 1500 nm 181.
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Figure 2-5: Operation and layout of integrated nanoDLD chips. (a) Schematic
representation of a DLD pillar array defining the gap size G, pillar pitch λ,
and row-to-row shift δ parameters, which determine the geometric angle,
θmax, along which larger particles are deflected. Particle trajectories are
illustrated for particles with diameters DP, above (blue) and below (yellow)
the critical diameter DC which depends on the geometry of the array. (b) Tilt
view optical image of the top side of a 22 mm × 30 mm nanoDLD chip,
showing the sample inlet and bump outlet via positions with corresponding
directional flow paths for injected sample (red) and outgoing bumped particle
(blue) fluids along with a common bus network. (c) Backlit optical image of
a nanoDLD chip (backside) revealing the through-hole via positions of the
sample inlet (red), bump outlet (blue), and zigzag outlet via bank (yellow).
(d) Optical microscope image highlighting the zoom-in section labeled in (b)
with superimposed flow paths for the sample inlet (red), zigzag mode
(yellow), and bump mode particle (blue) trajectories. NanoDLD arrays are
paired to common zigzag outlet vias or drains, where smaller particles DP <
DC exit to the backside of the chip into a common reservoir and larger
particles DP ≥ DC empty into a common bump outlet bus en route for the
bump outlet via. Scale bar = 400 μm. (e) Cross-sectional chip schematic
illustrating the process of sample injection with zigzag and enriched, bumpparticle fluid isolation and collection in common reservoirs on the backside
of the chip from the different via sets. (f) Optical microscope image showing
the labeled zoom-in section of (b) representing the layout of four parallel
nanoDLD arrays relative to the surrounding inlet bus, filters, zigzag outlet
vias, and bump outlet bus features. Scale bar = 300 μm. (g and h) Scanning
electron microscopy (SEM) image zoom-in locations of (f) along the array
outlet interface indicating the direction of larger DP ≥ DC particles bumping
at θ ≈ θmax toward the bump outlet bus (g) and smaller DP < DC particles
toward the zigzag outlet via drains (h) as they exit the array. Scale bars = 5
μm. (i) Tilt view cross-sectional SEM image of a G = 225 nm array (λ = 400
nm) with a pillar height of 1 μm, typical features of devices used in this
study. Scale bar = 400 nm. Reproduced with permission Smith et al., 2018.
Copyright 2018, Royal Society of Chemistry.
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A novel nano-DLD platform was reported by Wunsch et al. as an isolation
platform for colloids and exosomes ranging from 20 nm to 110 nm by fabricating an
array of pillars consisted of gap sizes between 25 nm and 235 nm. A drawback of this
platform was the very low fluidic volume rate (~ -0.2 μL h-1) that was caused due to the
integration of high hydrodynamically-resistive attributes 182. To overcome the issue, the
same research group developed another microfluidic device consisting of 1000 parallel
nano-DLD arrays (Figure 2-5) which resulted in an increase in the fluidic rate up to 900
μL h-1 presenting the immense potential of the platform for exosome separation and
analysis applications 178. Additionally, the platform showed superior exosome recovery
efficiency (~ 50%) compared to the other previously reported DLD platforms. Although
DLD is a very promising label-free and easily implementable exosome isolation method,
concerns related to low separation purity due to clogging are yet to be addressed.
2.4.2.5

Electroactive isolation technique
Electroactive isolation of different nanoparticles and exosomes is dependent on

the principle of separating particles based on their cellular compositions, diameters,
cytosolic conductivity, variation in dielectric constants, and membrane capacitance by
applying a non-uniform electric field either by generating alternating current across the
electrode arrays or by fabricating hurdles in the fluidic channel 183,184. The electric field
produces a continuous rotating flow pattern inside the microfluidic device that can result
in the separation of particles by moving them either out of the plane or near the electrode
185

. Two kinds of electroactive methods have been implemented by the researchers, also

known as electrokinetic filtration and dielectrophoresis, to isolate exosomes based on the
factors mentioned above. An electrokinetic filtration-based microfluidic device was first
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introduced by Davies et al. to drive the negatively charged exosomes from mouse blood
samples across the membrane and move the other particles in the opposite direction.
Later, Cho et al. implemented a microfluidic device with commercially available porous
membranes to isolate exosomes from diluted plasma while the protein and other larger
molecules were electrokinetically filtrated through the membrane. This device was able
to remove ~ 84% of the protein contents in less than 30 minutes with a 65% of recovery
rate that provided approximately 8 times higher than the conventional ultracentrifugation
technique 93. However, electrokinetic filtration causes bubbles formation on the
electrodes that can result in restricting the flow through the microfluidic channel. The
other form of the electroactive isolation method, dielectrophoresis, is dependent on the
dielectric constants of the particles. Insulator-based dielectrophoretic microfluidic device
has been reported for label-free isolation of exosomes subpopulation by generating low
DC voltage (10 V cm-1) across the pipette’s length 186. This device showed great promise
in capturing exosomes inhibiting closer to the pipette tip with an increase in the recovery
rate over time. Ibsen et al. developed a lab-on-a-chip dielectrophoresis device to isolate
glioblastoma exosomes from plasma samples in just 30 minutes by applying AC voltage
of 18 Vpp and 15 kHz. The on-chip isolation was conducted by developing a
dielectrophoretic high-field region combining the silicon dioxide layer and the fabricated
electrodes, which attracted the exosomes and excluded the larger particles. To validate
the captured exosomes on the microelectrodes, authors implemented SEM and in situ
immunofluorescence along with the specific CD63 and TSG101 antibodies 187. The same
platform has also been implemented to isolate exosomes from both serum and plasma
from Pancreatic Ductal Adenocarcinoma (PDAC) patients with ~ 99% sensitivity and ~
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82% specificity (Figure 2-6) 188. Dielectrophoresis-based exosome isolation is a very
promising high throughput method that can be implemented in clinical settings by
improving the flow velocity inside the microfluidic channel to increase the separation
efficiency of exosomes from various complex bodily fluids.
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Figure 2-6: (i) Schematic diagram illustrates the ACE (AC electrokinetic) direct
immunoassay procedure. Undiluted whole blood, plasma, or serum sample is
added directly to the chip. A 10- minute application of AC current to the chip
affects dielectrophoretic separation and isolation of target nanoscale
extracellular vesicles (EVs) and other particulates onto the chip electrodes.
Unbound material is washed off the chip with 0.5 X PBS during an additional
10 minutes of AC current. After the current is stopped, EVs and nucleic acid
targets can be analyzed by different methods, including the addition of
fluorescent reporter antibodies and nucleic acid dyes that are applied to the
chip, then incubated for the appropriate times. Following the final wash step,
the chip is ready for direct imaging and analysis of the fluorescent signal. (ii)
Whole blood from a pancreatic cancer patient is glypican-1 and CD63
positive in ACE Immunoassay. Panels A-C: Whole blood drawn from a
patient with PDAC was applied to an ACE chip (A); application of current
caused larger whole blood cells and particulates to migrate to low-field
regions between electrodes (B). A buffer wash removed most cells and
particulates from the chip (C). Panels D-F: Antibodies against glypican-1 and
CD63 were incubated together on the chip, followed by fluorophoreconjugated secondary antibodies for detection (D, CD63, green; E, glypican1, red; F, brightfield image). Panels G-I: As negative controls, primary
antibodies were omitted, and the fluorophore-conjugated secondary
antibodies alone did not label the electrodes (G, green channel; H, red
channel; I, bright field image). Reprinted (adapted) with permission from
Lewis et al., 2018. Copyright 2018, American Chemical Society.
2.5
2.5.1

Microfluidics-based exosome detection/analysis techniques

Fluorescence
Fluorescence is the most commonly used detection method of exosomes in

microfluidics-based isolation and analysis. There are numerous examples of fluorescence
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analysis of exosomes combined with different isolation methods. Kanwar et al. reported
integrated on-chip exosome isolation and analysis platform, ExoChip, which involved
specific antibodies to isolate exosomes from various body fluids (Figure 2-7).
Subsequently, the captured exosomes were stained with fluorescent dye followed by the
quantification using plate reader 89.
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Figure 2-7: (i) Illustration depicting the scheme of exosomes capture and analysis
procedure using ExoChip. The blood is collected for serum extraction from
healthy or diseased individuals and then exosomes are captured by flowing
serum through a CD63 antibody-coated ExoChip. To visualize the captured
exosomes, ExoChip is processed for membrane-specific dye (DiO) staining.
(ii) Experimental strategy for exosomes immobilization and characterization
using ExoChip, The ExoChip is designed to measure the levels of
fluorescently stained exosomes through fluorescence intensity measurements
using microplate readers and allows molecular characterization of Exosomes
contents through a variety of standard assays including protein analysis
(western blots) and mRNA/miRNA analysis (RT-PCR/miRNA open array).
(iii) A working prototype model of PDMS-based ExoChip (three channel)
depicting the flow of serum for exosomes capture in a typical experimental
setup. (iv) Characterization of Exosomes captured using ExoChip, A:
Fluorescence microscopy image of ExoChip channel depicting
immobilization of exosomes in native forms after DiO staining. High
magnification (400X) images of control one of the control chambers (B) and
anti-CD63 coated chambers depicting exosomes capture (C). Per the lightmicroscopy resolution limits the exosomes as visualized were found to be in
clusters which were also confirmed through confocal microscopy. D: A
confocal microscopic image showing a group of smaller exosomes (depicted
as dotted circles) forming a cluster (bar = 2μm). The native morphology of
the exosome vesicles was revealed following EM analysis. Electron
micrograph images showed the absence of any vesicle immobilizations in
control ExoChip (E), whereas the anti-CD63 coated ExoChip (F) showed the
presence of exosomes both in clusters as well as single vesicles (bar =
500nm). G: A magnified view of a single exosome vesicle as examined under
EM depicting a cluster of exosomes (bar = 100nm). Reprinted (adapted) with
permission from Kanwar et al., 2014. Copyright 2014, Royal Society of
Chemistry.
Recently, a homogeneous magneto-fluorescent exosome (hMFEX) nanosensor
has been developed for rapid and on-site tumor-derived exosomes analysis 189. This
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integrated approach was able to detect the tumor-derived exosomes with high specificity
having the limit of detection of 6.56 × 104 particles μL-1 which demonstrates the excellent
potential of high clinical diagnostic efficacy of the hMFEX nanosensor 189. Another more
recent study reported a fluorescence analysis method to quantify and differentiate
between the normal and metastatic Sentinel lymph node (SLN) derived exosomes
captured using silicon nanoparticles-based exosome probes (SiNPs@EXO) 190.
Fluorescence analysis depicted that fluorescence signal in metastatic SLNs reached a
peak within 30 minutes and stayed up to 3 hours, whereas, normal SLNs attained the
peak in about an hour followed by a sudden decrease in the signal 190. This integrated tool
showed amazing potential for predicting lymphatic metastasis of tumors by targeting
SLNs.
2.5.2

Colorimetric
Colorimetric detection is based on the principle of identifying a sample by

comparing the color depth of a chromogenic material. Colorimetric detection has been
integrated with microfluidics by many researchers to visualize the capture and analysis of
exosomes. Vaidyanathan et al. reported a microfluidic platform with functionalized
electrodes specific for capturing exosomes. The electrode surface was responsible for
generating nanoscale fluid flow, and the absorbance measurement of the colorimetric
solution was used to detect and quantify exosomes with high specificity. This platform
showed superior sensitivity compared to other fluid dynamics-based approaches 191.
Another sensitive and selective colorimetric aptasensor was successfully implemented for
the detection of cancer-derived exosomes facilitated by the polymerization of horseradish
peroxidase (HRP)-accelerated dopamine (DA) and in situ deposition of polydopamine
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(PDA) 192. For this study, the target exosomes were firstly isolated by latex beads,
followed by bio-recognition using a specific CD63 aptamer, which was conjugated to
horseradish peroxidase (HRP) through biotin-streptavidin binding 192 (Figure 2-8).
Colorimetric detection was completed in 10 minutes via enzymatic catalysis which
produced dark colored polydopamine (PDA) as a result of the enzymatic reaction
between DA and monoamine oxidase that was quantified using absorbance measurement.
The color depth correlated to the CD63 amount and the limit of detection (LOD) was
found as 7.7 × 103 particle mL-1, increasing the LOD by 3-5 orders of magnitude from
conventional Dot-blot methods 192.
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Figure 2-8: Schematic illustration of the proposed aptasensor with HRP accelerated
dopamine polymerization and deposition for exosome detection
(ExoAptaSensor). (A) (I) Exosomes anchored on sulfate/latex beads were
captured by biotin-conjugated aptamer specific to CD63, followed by
incubation with streptavidin-conjugated HRP for colorimetric reaction to
convert colorless Dopamine (DA) into brown-black colored Polydopamine
(PDA) in 10 min in Tris buffer (pH 8.5). This oxidation and polymerization
process is accelerated under HRP catalysis and hydrogen peroxide (H2O2) as
the oxidant. (II) Color developed by this aptasensor correlates to exosome
concentrations and allows simple naked eye visualization. (III) Absorbance
signals of the product can also be quantified at 400 nm. (B) Scheme shows
the poly-deposition process of PDA onto surface proteins of exosomes in
situ. (C), (D), (E), (F) illustrates Proof-of-concept study of ExoAptaSensor.
(C) Color intensity of PDA deposition at the target site of HRP where the
concentration of H202 varied from 0% to 2%. (D) Color intensity measured
at intervals of 0, 1, 2, 10-, 20-, 30- and 60-min using ImageJ. (E) Digital
images were taken right after color development of exosome samples in
solution using the CD63 ExoAptaSensor. Color intensity was dependent on
exosome concentrations (1010, 108, 106, 103, and 0 (blank) particles,
respectively). (F) Absorbance spectra were obtained at wavelengths from 300
nm to 600 nm, with a peak at 400 nm correlates with the changes in exosome
concentrations. This supports the ability of the developed colorimetric
aptasensor for exosome detection. Reprinted from Development of a simple,
sensitive, and selective colorimetric aptasensor for the detection of cancerderived exosomes, Volume 169, Xu et al., 2020a, Page No. 112576,
Copyright 2020, with permission from Elsevier.
Another research group proposed a highly sensitive plasmonic colorimetric
biosensor for exosome quantification. The two-step sensing technique involved exosomeinduced competitive reaction and etching of gold nanobipyramid@MnO2 nanosheet
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nanostructures (Au NBP@MnO2 NSs) 193. A competitive reaction induced by exosomes
translated the signal of exosomes into the amount of alkaline phosphatase, which
simplified the experimental process and amplified the signal. On the other hand, the
etching of Au NBP@MnO2 NSs by ascorbic acid altered the refractive index of Au
NBPs, accompanied by the blue shift of the longitudinal localized surface plasmon
resonance peak. Aided by the signal amplification of the competitive reaction and
outstanding refractive index sensitivity of the colorimetric substrates, this process
demonstrated high sensitivity within 8.5 × 102 to 8.5 × 104 particles μL–1 of exosomes
along with a detection limit of 1.35 × 102 particles μL–1, providing proof of superior
sensitivity of exosomes detection than previously reported colorimetric methods 193.
2.5.3

Magnetic based methods
Traditional nuclear magnetic resonance (NMR) is widely used to perform

chemical analysis but cannot be readily implemented for the detection of exosomes due
to their very small sizes. Because of their ultrasmall sizes, exosomes demonstrate a very
low signal-to-noise ratio (SNR) in micro-nuclear magnetic resonance (μNMR), which
was first reported by Issadore et al. as a modified version of NMR exclusively for
capturing small particles such as exosomes 194. To improve the process, Shao et al.
developed a microfluidics-based μNMR device that could simultaneously quantify the
exosomes and the protein contents inside them. The exosomes were isolated using
immunomagnetic nanoparticles (IMNPs) followed by filtrating the IMNP-labeled
exosomes 195. The presence of INMPs converts the complexes found in the IMNPcaptured exosomes into super magnetic, therefore, increased the SNR of the process. This
reported platform showed very good detection sensitivity coupled with high
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reproducibility 195. Recently, Sancho-Albero et al. reported a continuous-flow
microfluidic device for the isolation and analysis of exosomes from the whole blood
sample, fetal bovine serum (FBS), and PBS of pancreatic cancer (PC) patients integrating
CD9-mediated magnetic capture (Figure 2-9). The identity of the tetraspanins was
verified by the coexpression of a second exosomal protein CD63 quantified by a CD63
ELISA test. Finally, exosomes from the whole blood of PC patients were captured and
the exosomal CA19-9 protein levels were evaluated. The results show the potential of
exosome separation and analysis as a marker of PC progression 196. However, the main
challenge for the μNMR detection method remains the complexity of this technique for
point-of-care diagnosis.
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Figure 2-9: (a) Operation principle of the coaxial mixer. (b) ELISA analysis against
CD63 and CA19-9 was performed after exosome capture from whole blood.
(c) Left: Image of setup. Right: The pipe is lifted from the magnets showing
the NPs captured at the junctions between the alternate polarization magnets.
d Simulation of the magnetic gradient created between each pair of NdFeB
magnets. Nanoparticle accumulation coincides with the high-intensity nodes.
The tubing is represented with solid and dashed blue lines. Reproduced with
permission from Sancho-Albero et al., 2020 under Creative Commons
Attribution License (CC BY 4.0), Copyright 2020, Springer Nature.
2.5.4

Surface plasmon resonance (SPR)
Surface plasmon resonance (SPR) is defined as a type of resonant oscillation of

the electrons caused by the electric field components of the incident light at the interface
between a negative and a positive dielectric constant material. This oscillation is prone to
any sensitive change in the boundary conditions which is often employed by the
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researchers to detect various biomolecules 197,198. Microfluidics-based SPR is an
emerging method of exosome isolation due to its cost-effectiveness, portability, and the
ability of very fast label-free detection. One of the pioneering works regarding this
method presented an on-chip SPR sensor that was able to isolate and quantify various
exosomal proteins. The authors modified the gold surface with the antibodies and used
antibody microarrays to capture exosomes which led to a change in the refractive index
199

(Figure 2-10). Using this method, they were able to quantify and analyze various

exosomal proteins simultaneously.

Figure 2-10: Schematic view of SPRi in combination with antibody microarray to
capture and detect exosomes in the cell culture supernatant. Antibodies
specific to exosome transmembrane proteins were printed on the gilded gold
chip. The optical path from the laser passes through the coupling prism at a
fixed angle of incidence, and the reflection is recorded by a CCD camera.
Upon injection of sample into the flow cell, exosomes can be captured by
antibodies on the chip, resulting in changes in the refractive index and
therefore changes in the reflection intensities, which are monitored by the
CCD camera. Reproduced with permission from Zhu et al., 2014 (article link:
https://pubs.acs.org/doi/10.1021/ac5023056), Copyright 2014, American
Chemical Society. Any future use of this content is subjected to permission
from ACS Publications.
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Recently, W. Chen et al. reported a novel label-free real-time surface plasmon
resonance imaging (SPRi) biosensor based on the hydrogel-AuNp supramolecular sphere
(H-Au) for very sensitive and specific detection and quantification of prostate cancer cellderived exosomes. Before the detection, the localized surface plasmon resonance (LSPR)
effect of AuNPs and the signal amplification effect of the mass cumulative hydrogel were
integrated with highly specific aptamer 200. This developed sensor showed an
extraordinary wide linear range of detection between 1.00 × 105 and 1.00 × 107 particles
mL-1 and has a limit of detection of 1.00 × 105 particles mL-1

200

. Additionally, the SPRi

signal maintained a very strong correlation with the t-PSA value measured by the
clinically implemented chemiluminescence immunosensors. Therefore, this
microfluidics-based SPR biosensor revealed exceptional feasibility for human
serum analysis and would carry a great potential in biomolecular analysis and point-ofcare diagnosis.
2.5.5

Electrochemical
Electrochemical process is a highly apposite detection method for biomolecular

analysis including exosomes due to very simple protocol, ease of integration with the
microfluidics platforms, and high sensitivity 201. In electrochemical detection, the
antibody or aptamer element attaches specifically with exosomes, therefore, generating
an electrochemical signal altered by the exosomes which are used to quantify and analyze
the exosomes 202,203. Electrochemical detection has been used for the successful detection
of various biomarkers and biomolecules, including exosomes 204,205. One of the
pioneering works by Zhou et al. reported an aptamer-based electrochemical biosensor for
quantitative detection and analysis of exosomes by immobilizing the aptamers specific to
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exosome tetraspanin protein, CD63, onto gold electrodes and integrating this into a
microfluidic platform. The concentration of exosome was quantified by measuring the
signal generated when combining the methylene blue (MB)- labeled probe strand and the
exosome-specific aptamer. Signal output decreased in presence of exosomes as they tend
to displace the probe strands 202. This reported biosensor was able to detect 1 × 106
particles mL-1 of exosomes, which replicated an approximately 100-fold improvement in
the limit of detection (LOD) in comparison with the commercial immunosensors based
on anti-CD63 antibodies 202. Recently, another research group has reported a detachable
microfluidic device integrated with an electrochemical aptasensor (DeMEA) for highly
sensitive and in-situ quantitative detection of cancerous exosomes 206 (Figure 2-11). The
authors immobilized an aptamer specific to the epithelial cell adhesion molecules onto
the gold-plated electrode for very specific detection of the cancerous exosomes.
Additionally, a microfluidic vortexer was integrated using 3D printed magnetic housing
to escalate the collisions between the exosomes and sensing surface using
hydrodynamically generated transverse flow 206. The reported platform exhibited high
sensitivity and high specificity with an opportunity to consequently culture exosomes for
downstream analysis by utilizing the detachable nature of the device. Moreover, the
DeMEA displayed an ultra-low limit of detection of 17 exosomes μL-1 over a wide
dynamic range (1 × 102 to 1 × 109) exosomes μL-1 in less than 50 minutes 206.
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Figure 2-11: (i) Schematics of complete detachable microfluidic analysis system with
electrochemical aptasensor (DeMEA) for sequential analysis of cancerous
exosomes. (ii) Clinical plasma samples analysis to quantify the exosomes
derived from MCF-7 cancer cells using the developed DeMEA and ELISA.
The results obtained from the DeMEA and ELISA are represented in (a) bar
graph, (b) scatter graph. All measurements were carried out in triplicate, and
error bars correspond to standard deviations from independent measurements
(n = 3). Reprinted from Detachable microfluidic device implemented with
electrochemical aptasensor (DeMEA) for sequential analysis of cancerous
exosomes, Volume 169, Kashefi-Kheyrabadi et al., 2020, Page No. 112622,
Copyright 2020, with permission from Elsevier.
2.6

Conclusions and discussions

This chapter summarizes the biological functions of exosomes and their roles as
various disease biomarkers as well as in point-of-care diagnostics. Additionally, the
conventional isolation and detection methods have also been discussed with their
respective advantages and disadvantages. In the latter half of the chapter, microfluidicsbased exosome isolation and detection methods, their basic principles, the reasons behind
the emergence of microfluidics-based exosome capture and analysis, their respective
advantages and disadvantages, and the latest advancements in microfluidics-based
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exosome isolation and detection have been discussed in detail. Although microfluidics
provides a rapid and more accurate quantification and analysis of exosomes from various
biofluids compared to the conventional techniques, the biggest challenge is to perform
high-throughput exosome separation with high purity, minimal damage, and high yield.
Due to the heterogeneous nature of the exosomes, it is often very difficult to obtain
highly pure exosomes that result in lowering the accuracy. With the ongoing efforts from
the researchers for integration of exosomes isolation and detection methods with the
microfluidics platform, it is expected that the next major step in this field will be the
emergence of point-of-care devices for applications in clinical settings.

DEVELOPMENT OF ANTIBODY FUNCTIONALIZED PROBE FOR
SELECTIVE PURIFICATION OF EXOSOMES†

3.1

Background

As discussed previously in chapter 2, The clinical applications of exosomes have
not been fully realized due to technical challenges associated with traditional and newer
methods for exosome isolation. Inefficient purification techniques lead to the extraction
of heterogeneous extracellular vesicles that have different sizes, surface proteins, or
cellular origins. Selective isolation of surface-protein marker-specific exosomal
subpopulations for subsequent genetic analysis is critical in studies to evaluate their
clinical relevance 101. For example, CD63-positive exosomes are present at a higher level
in malignant cells compared to healthy ones 141, while exosomes secreted in cerebrospinal
fluid carry specific markers such as Alix, syntenin-1, heat shock proteins, and
tetraspanins 68 that may provide crucial information for neurodegenerative disorders.
Exosomal membranes are enriched in tetraspanins (CD63, CD9, and CD81) that are used
as biomarkers for disease diagnostics and prediction of therapeutic response

†

This chapter or portions thereof has been published in Talanta under the title “ExoPRIME: Solid-phase
immunoisolation and OMICS analysis of surface-marker-specific exosomal subpopulations”. Volume
236 (2022). DOI: 10.1016/j.talanta.2021.122870. The current version has been formatted for this
dissertation.
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The challenge to develop a purification technique that can selectively isolate
exosomes rapidly, reproducibly, efficiently, for clinical and research applications has
been recognized in the scientific community. Multiple technologies that improve
exosomal isolation have been developed by exploiting the biochemical properties of
exosomes, and the process has rapidly evolved in recent years 47,182. While these
conventional techniques have advantages and disadvantages, they all purify a population
of exosomes that express different surface markers. A rapid, and antigen-selective
technology that provides high-purity exosomal subpopulation will accelerate extracellular
vesicles research and the development of exosome-based products and applications. The
Dynabeads® magnetic separation technology is highly specific and has a highly
concentrated yield and purity at the time of capture, in addition to ensuring the integrity
of isolated exosomes 136. However, the pH and ionic concentrations of the reagents
required to elute the exosomes from the stationary phases for downstream analysis can
easily alter the properties of most of the exosome products, rendering them inadequate as
best-practice models for exosome utilization. The greatest limitation to widespread
adoption of the immunoaffinity-based method is its high reagents cost that limits the
sample volume being analyzed. To overcome the identified technical challenges,
traditional exosome purification technologies are sometimes used in combination in an
attempt to provide a simple, fast, efficient, and affordable technique for the solid phase
isolation of exosomes. A novel ultrafast-isolation system called EXODUS employs a
nanoporous membrane to rapidly isolate and concentrate exosomes from biofluids via
acoustofluidic streaming 176. Despite advantages over existing methods, the negative
oscillatory pressure applied to the sample could lead to reduced integrity of the exosomes
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in the sample. To date, no one has successfully developed a microprobe-based method for
direct and high-throughput purification of intact exosomes.
In this study, we developed a method for immobilization of CD63 antibodyconjugated to streptavidin for the purification of surface marker-specific exosomes
(Figure 1-2). The ExoPRIME tool provides a Precise Rapid Inexpensive Mild (noninvasive) and Efficient (i.e., PRIME) alternative for exosome isolation and analysis. The
current prototype: (1) is a portable and affordable platform that does not require large,
expensive equipment, (2) operates in situ and eliminates the time-consuming, multistep
protocol for additional pre-concentration steps of the biological specimen, (3) enables
selective isolation of exosomes with a high-spatial-resolution, (4) provides flexibility in
parameters selection to scale yield and speed, (5) permits reusability of the specimen
multiple times, and (6) could allow integration with microfluidics-based standard systems
for genomic and proteomic analysis of exosomal cargoes. Thus, this direct, single-step
ExoPRIME Microprobe Technology holds promise for real-time exosome sample
collection which can be applied for exosome enrichment and analysis of clinical
specimens.
3.2
3.2.1

Materials and methods

Design and fabrication of the ExoPRIME microprobe
The novel ExoPRIME microprobe technology provides direct, in situ enrichment

of intact exosomes based on immunoaffinity, without compromising their structure by
avoiding the shear strain during centrifugation. We employed a multidisciplinary
approach that includes thin-film immobilization, nanoscience, and immunobiology, to
design, fabricate, and characterize a “smart microprobe” for purification of the antigen-
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specific exosome. The ExoPRIME tool consists of an inert Serin™ stainless steel
microneedle (300 μm × 30 mm) functionalized with an antibody (anti-CD63) that
selectively binds to the corresponding tetraspanin embedded in the lipid bilayer of the
exosomes. After incubation in a biofluid, the exosome capture efficiency is assessed via
a fluorescent assay. Layer-by-layer (LbL) assembly was applied to create the precursor
layer of six alternating polyethyleneimine/polyacrylic acid bilayers [PEI/PAA]6 for the
immobilization of biotin to the stainless-steel surface of the probe. 1-Ethyl-3-(3-dimethyl
aminopropyl) carbodiimide (EDC) mediated chemical linkage of amine-modified biotin
to the carboxyl group of the PAA and was followed by the biotin-streptavidin covalent
linkage of the CD63 antibody (Figure 3-1).

Figure 3-1: ExoPRIME probe functionalization workflow.54
3.2.2

Characterization of the microprobes to validate LbL precursor
Hitachi S-4800 field-emission scanning electron microscope (FESEM) that is

located at the IFM facilities in Louisiana Tech University was used to characterize the
layer-by-layer assembly functionalization of the polyelectrolytes on the microprobe
surfaces. At first, the sample was attached to a 5mm sample plate. Then the sample was
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loaded inside the specimen exchange chamber of the instrument and carefully placed in
the holder receiver. Once the specimen was placed, the gate valve between the main
chamber and the specimen exchange chamber was closed, and the sample was ready to
image. For the imaging of the microprobes, secondary electron (SE) image signal, normal
probe current, and ultra-high resolution (UHR) focusing mode was selected. For normal
imaging, the vendor instructed beam acceleration voltage is 1-5 kV, which was
maintained to image the microprobe samples. 3 kV and 5 kV beam acceleration voltages
were used to image the needles. Beam alignment was performed in both low and high
magnification modes (400X, and 2000X respectively) to obtain the best possible images.
A control experiment was performed with a plain microprobe using the same
specifications. To further investigate the functionalization process, EDX was used along
with FESEM on both plain and functionalized microprobes. EDX analysis confirms
traces of the elements of the polyelectrolytes for the functionalized needles which are not
found in the plain needles
3.2.3

Confirmation of anti-CD63 antibody immobilization
Nikon Eclipse TE2000-U inverted microscope was used to evaluate the binding

reaction between biotin with captured streptavidin. Polyelectrolyte functionalized
microprobes were immersed and incubated for 1 hour at 37℃ inside the stock biotin
solution followed by rinsing in 10mM MES buffer and air drying. After that 2 𝜇g mL-1
anti-CD63 antibody solution, which was conjugated to streptavidin, was prepared from
1mg/mL stock anti-CD63 antibody (with streptavidin) in PBS buffer with 1:1000
dilution. Later, the needles were dipped into the solution for 2 hours, rinsed with PBS
buffer, and air-dried. To evaluate the binding reaction between biotin with captured
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streptavidin, needles with immobilized streptavidin were immersed in 0.4 M (258 𝜇g 𝜇L1

) fluorescence-labeled biotin (biotin-FITC). The needles were incubated (after covering

with aluminum foil to avoid photobleaching) into the solution at room temperature for 30
minutes, washed with PBS buffer, and air-dried. Later, the microprobes were studied
under a fluorescence microscope using excitation/emission 490nm/516nm and exposure
time 100 msec. Two control experiments were performed by omitting the streptavidin
and the LbL precursor layers respectively.
3.3
3.3.1

Results and discussions

Structural characterization of the LBL deposition on microprobe surfaces
The efficiency of the thin film deposition was assessed via scanning electron

microscopy (SEM) coupled with energy-dispersive x-ray spectroscopy (EDX). Images
obtained with a Hitachi S-4800 field-emission scanning electron microscope (FESEM)
are shown in Figure 3-2 and confirms that the film adsorption protocol provides efficient
and stable deposition of polyelectrolyte precursor layers, for subsequent immobilization
of biotin and streptavidin-conjugated anti-CD63 antibody. A control experiment was
performed using a plain microneedle using the same imaging settings. The SEM images
of the LbL-coated microneedle (Figure 3-2B, E), compared to the control samples
(Figure 3-2A, D), show a denser material that appears as froth-like coverages on the
faces and borders, while the conical outline of the microneedle is still maintained in both
instances. The slight roughness observed on the control samples is a result of the
sandpaper polishing and chemical etching, but devoid of polyelectrolyte bilayers. Both
EDX spectra (Figure 3-2C) confirm the presence of the metallic constituents of stainless
steel; iron, chromium, carbon, and other alloying elements such as nickel, manganese,
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and silicon 207. Additionally, in the LbL-coated sample (Figure 3-2F), we see traces of
hydrocarbons (much higher carbon, oxygen) and nitrogen – consistent with the chemical
composition of the polyelectrolytes used for the coating, supporting the SEM results.
These experiments were performed with multiple arrays of microneedles, and they all
showed the feasibility and reproducibility of the LBL assembly process.

Figure 3-2: SEM micrographs of the tips (left panels) and stem (middle panels) of
polished plain needles (A, B) and LBL-coated microneedles (D, E), showing
successful and efficient deposition polyelectrolyte bilayers. The right panels
show the corresponding EDX spectra of plain (C) and LBL-coated (F)
microneedles.54
3.3.2

Validation of the antibody immobilization using fluorescence analysis
Efficient and selective capture of CD63+ (or other antigen-presenting)

subpopulation of exosomes is an essential parameter for the accurate identification of
exosomal biomarkers. The anti-CD63 antibody selectively binds to the surface protein
marker expressed by exosomes. CD63 was selected for this study because its
overexpression has clinical implications in tumorigenesis and metastasis. The efficiency
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of biotin immobilization was assessed using fluorescein (FITC)-labeled biotin (Figure
3-3). Streptavidin-functionalized needles were incubated in biotin-conjugated FITC
solution (Figure 3-3A, D) and imaged under a Nikon Eclipse TE2000-U inverted
fluorescence microscope, 20x objective. Two different negative control experiments were
performed to evaluate the non-specific binding of biotin to the stainless-steel surface of
the needle (B) and the polyelectrolyte precursor layer (C). The relatively high corrected
total probe fluorescence (CTPF) observed in the fully functionalized microneedle (A, D),
and the almost non-existent fluorescence in the two negative control samples (B, C, D),
confirm the strong attachment of the fluorescence-labeled biotin (biotin-FITC) to the
LBL-coated and streptavidin-functionalized microneedle. Although FITC has been
reported to promote adsorption of FITC-labelled proteins 208, the less pronounced
fluorescence by biotin-FITC in the negative controls further emphasized the importance
of the LbL base and EDC-cross-linked avidin in the LbL-biotin chemistry in determining
the functionality of the probe.
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Figure 3-3: Fluorescent images confirming successful LBL assembly and Biotin
immobilization on microneedles: (A) LbL+Biotin-EDC+Streptavidin+BiotinFITC; (B) LbL+Biotin-FITC; (C) Biotin-FITC. (D) ImageJ analysis of the
CTPF of A, B, C.54

CALORIMETRIC SANDWICH-TYPE IMMUNOSENSOR FOR
QUANTIFICATION OF TNF-𝛂†

4.1

Background

Recent years have witnessed significant progress in the development of more
efficient detection technologies for lab-on-a-chip immunoassays that provide increased
sensitivity and specificity for point-of-care applications. Microfluidics immunosensors
offer multiple advantages that include increased reaction rate, decreased time for
incubation of the reactants, and reduced reagents and samples consumption.
Miniaturization and integration of the multiple assay components allow automation,
precise control of the fluid velocity, increased reproducibility, and the possibility for
high-throughput analysis 2. A wide range of detection technologies has been integrated
with lab-on-a-chip biosensors for the quantification of analytes in biological and
chemical samples. The optimal detection method provides high sensitivity coupled with
low power consumption, simple fabrication, and minimal sample preparation 3.
Fluorescence, chemiluminescence, and electrochemiluminescence techniques provide
detection sensitivities in the ng-pg mL-1 range 4. While these detection methods are well-

†
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established, each of these techniques has limitations. Major drawbacks of the
electrochemical detection technology are the effect of external factors such as pH,
temperature, and ionic concentration on the performance of the assay 12.
Calorimetric microfluidic systems with integrated miniaturized thermopile
sensors are employed to measure small quantities of heat for biosensing applications.
Here we report a calorimetric sandwich-type microfluidic immunoassay for detection and
quantification of TNF-α using a thin-film thermopile that is attached to the lower channel
wall of the device. The calorimetric immunosensor was fabricated using xurography, an
inexpensive, rapid prototyping method for the manufacture of high aspect ratio
microfluidic devices. Compared to other emerging low-cost benchtop technologies like
3D printers or laser cutters, “razor writing” of thin films is an attractive alternative for the
fabrication of point-of-care devices. The described method uses a cutting plotter to create
microstructures from adhesive tape in less than 3 minutes without photolithographic
processes or chemicals. Simplicity and low cost of device fabrication that does not
require special facilities such as clean rooms or specialized laboratory equipment for
photolithographic processing of materials are advantages derived from this
manufacturing technology. The sensor converts the temperature difference caused by the
enzymatic reaction between glucose and glucose oxidase conjugated TNF-α detection
antibody into an electric signal that is recorded by a nanovolt meter. The total amount of
heat that is generated is proportional to the concentration of the analyte. The sensor is
small in size (8mm×8mm), light in weight, consists of 60 antimony-bismuth (Sb-Bi)
thermocouple junctions and is relatively simple to fabricate. The miniaturized thermopile
offers rapid response time and provides a self-generating signal that does not require
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external power. The sensor operates without any control of external temperature because
of its high common-mode thermal noise rejection ratio. The major advantages of the
calorimetric immunosensor are the elimination of the control of light and signal
development timing, a common requirement for conventional microplate-based TNF-α
assays. Since calorimetric measurements are based on the detection of the heat released
during an enzymatic reaction, the immunoassay can be performed with a wide range of
enzyme-conjugated detection antibodies. The assay is performed in a flow-through
system and unbound antibodies are washed away by the fluid in the microchannel. The
design of the system allows the substrate to be introduced multiple times after the signal
returns to baseline level to increase the statistical significance of the results.
4.2
4.2.1

Materials and methods

Principle of calorimetric immunosensing
Calorimetric quantification of TNF-𝛼 was successfully demonstrated in a

microfluidic device with an integrated thin-film Sb-Bi thermoelectric sensor with a
theoretical Seebeck coefficient of 7.14 μV mK-1. The technique is based on sandwiched
immunodetection using a pair of matched antibodies that recognize different epitope sites
of the TNF-α cytokine. The antibody-analyte complex was immobilized within the
measuring junctions of the thermoelectric sensor. A fixed concentration of glucose (55
mM) was injected through a sample loop into the fluid flowing within the microfluidic
device. The oxidation of glucose to gluconic acid by glucose oxidase generates 79 kJ
mol-1 of energy 209.
𝑮𝒍𝒖𝒄𝒐𝒔𝒆 𝑶𝒙𝒊𝒅𝒂𝒔𝒆

Glucose + O2 + H2O →

𝒌𝑱

Gluconic acid + H2O2 + 79 𝒎𝒐𝒍

65
The enzymatic reaction increases the localized temperature at the measuring
junctions of the thermopile in respect to the reference junctions and is proportional to the
concentration of TNF-α that is measured in the cell culture medium of human astrocytes
(Figure 4-1).

Figure 4-1: Principle of calorimetric immunosensing. The amount of heat released during
the enzymatic reaction between the glucose oxidase conjugated detection
antibody and glucose is proportional to the concentration of TNF-α in the
biological sample 83.
4.2.2

Experimental set-up
A schematic of the calorimetric system for immunosensing is shown in Figure

4-2. Two syringe pumps (Harvard Apparatus, Holliston, MA) independently inject
sodium acetate buffer through 0.01-inch internal diameter Teflon tubing (Upchurch
Scientific, Oak Harbor, WA). A sample loop that has a volume of 13µL was loaded with
55mM glucose that was introduced into the inlet 2 buffer stream via a 6-port injection
valve (V-451, Upchurch Scientific, Oak Harbor, WA). The thermal signature of the
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enzymatic reaction is detected and converted by the thermopile sensor to an electric
signal that was measured with a nanovolt meter (Agilent, model #34430A Loveland,
CO). The output signal was recorded and processed using LabView SignalExpress
software (National Instruments, Austin, TX). To prevent external electromagnetic
interferences with the signal recording, the device and the nanovolt meter instrument
were housed in a Faraday cage.

Figure 4-2: Schematic diagram of the setup for calorimetric immunosensing of TNF-α 83.
4.2.3

Fabrication of immunosensor
The microfluidic device has two inlets and a single outlet for independent

injection of glucose and 50mM acetate buffer (pH 5.5) and was fabricated using a rapidprototyping technique (Figure 4-3A). The channel of the device was designed using
Adobe Illustrator software (Adobe, San Jose, CA) and was cut out of 100µm thick
Kapton® tape using a cutting plotter (Graphtec America Inc, Santa Ana, CA). The
dimensions of the channel were 65mm×12mm×0.1mm. The upper and lower channel
walls consisted of 75mm×25mm×1mm microscope glass slide (VWR, Radnor, PA) and
75mm×25mm×0.17mm glass cover slip (Electron Microscopy Sciences, Hatfield, PA),

67
respectively. Streptavidin was immobilized to the lower channel wall of the device via a
layer-by-layer self-assembly technique. The glass coverslip was cleaned with a 2% Micro
90 cleaning solution (Sigma Aldrich, St. Louis, MO). Five layers of alternating
polyethyleneimine (50% w/v) and polyacrylic acid (35% w/v) (Sigma Aldrich, St. Louis,
MO) were applied to a carboxylated layer of the surface of the device. EZ-Link™ NHSPEG4 Biotinylating Kit (ThermoFisher Scientific, Waltham, MA) was used to
functionalize the surface with streptavidin. The sensor (Figure 4-3B) was fabricated on
100μm polyimide tape using a Denton model DV-502B metal evaporation system
(Denton Vacuum, Moorestown, NJ)43 and was attached to the outer surface of the lower
channel wall with a silver thermal compound (Arctic Silver Inc., Visalia, CA).

Figure 4-3: (A) Microfluidic device for calorimetric detection of TNF-α. (B) Image of
thin-film Sb/Bi thermopile sensor. The reaction zone was located above the
measuring junctions 83.
4.2.4

Calorimetric immunoassay procedure
Human TNF-α matched antibody pair kit (ab213467, Abcam, MA) was used for

the quantification of the analyte. The capture antibody was conjugated to biotin while the
detection antibody was labeled with glucose oxidase using a glucose oxidase conjugation
kit (ab102887, Abcam, MA) according to the vendor guidelines. Cell culture supernatant
from lipopolysaccharide (LPS) treated and non-treated human astrocytes (ScienCell
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Research Laboratory, Carlsbad, CA) was collected, centrifuged at 2,000 g for 10 minutes
to remove cell debris and stored at -20°C. A standard calibration curve was created using
serial dilutions of synthetic TNF-α (0-2000 pg mL-1). Twenty μL of biotin linked capture
antibody (2μg mL-1) and glucose oxidase conjugated detection antibody (0.5 μg mL-1)
were mixed with 20μL of synthetic TNF-α and incubated on an orbital shaker for 1 hour
at medium speed. The same protocol was followed for the analysis of biological samples
from cell culture supernatant from human astrocytes. The complex of the antibodies and
the analyte was immobilized to the lower channel wall of the device via the biotinstreptavidin covalent bond. The dimensions of the reaction zone were 8mm×3mm and
were located directly above the measuring junctions of the sensor. Sodium acetate buffer
was introduced through inlets 1 and 2 of the microfluidic device with a flow rate of
100μL min-1 and 25μL min-1 respectively. Glucose (55mM) was loaded into a 13μL
sample loop and injected into the buffer stream of inlet 2 via an injection valve. The heat
generated by the enzymatic reaction between the glucose and the glucose oxidase
conjugated detection antibody increased the temperature at the measuring junctions of the
thermopile. The magnitude of the voltage signal was calculated by integrating the area
under the curve (AUC) versus the time profile using the Riemann Sums trapezoid rule. A
standard calibration curve was generated by plotting the concentration of synthetic TNFα versus the average AUC of the thermoelectric response. To evaluate the accuracy of the
developed immunosensor, the concentration of cytokine in the cell culture supernatant
was measured using human TNF-α ELISA kits (ab46087, Abcam, MA) according to the
vendor’s guidelines.

69
4.2.5

Numerical analysis of glucose concentration as a function of the volumetric

flow rate
The concentration of glucose along the width of the microchannel was modeled as
a function of inlet 1 and inlet 2 fluid velocity. The simulations were performed using
COMSOL Multiphysics 5.2a software. The developed two-dimensional stationary model
was based on a microchannel with dimensions 65mm×12mm. The simulation results
were obtained using the laminar reacting flow module coupled with the transport of
diluted species module. The velocity distribution along the microchannel was assumed to
follow Newtonian laminar flow. The fluid was considered incompressible with no-slip
boundary conditions applied at all the walls. To run the simulation, a physics-controlled
mesh with a finer element size was chosen. The dimensions of the microchannel and the
fluid velocity parameters used in the simulations are listed in Table 4-1. The velocity of
inlet 1 was constant while the velocity of inlet 2 was decreased to investigate its effect on
the glucose distribution profile.
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Table 4-1: Microfluidics dimensions and fluid flow model parameters.
Channel length
Channel width
Internal diameter of inlet and outlet
Glucose diffusion coefficient
Inlet 1 fluid velocity
Flow ratio
Inlet 2 glucose velocity
Reaction rate
Inlet temperature
Outlet Pressure
Mesh
4.3
4.3.1

65mm
12mm
0.254mm (0.01 inch)
6.7×10-10 m2s-1 210
6.7×10-4 ms-1
1,2, 4
6.7×10-4 ms-1/Flow ratio
3×10-7mol m-3s-1 211
293.15K
0 atm
Finer element size

Results and discussions

COMSOL simulations of the glucose concentration profile
The COMSOL model has been used to characterize the distribution of the

substrate along the width of the microchannel as a function of inlet 2 fluid velocity. The
concentration of glucose within the reaction zone was proportional to the volumetric flow
rate of inlet 2 and the ratio of the fluid velocities between both inlets (Figure 4-4).
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Figure 4-4: Glucose concentration profile along the width of the microchannel. Inlet 1
velocity is 6.7×10-4 m s-1. Inlet 2 flow velocity is: (A) 6.7×10-4 m s-1; (B) 1.67
×10-4 m s-1; (C) 0.84 ×10-4 m s-1. (D) Graphical representation of glucose
concentration along the width of the microchannel for various velocity flow
ratios 83.
The buffer supplied through inlet 2 was hydrodynamically focused within the
measuring junctions of the thermopile by the fluid introduced through inlet 1. Change in
the velocity ratio between both inlets affected the width of the glucose stream above the
reaction zone. An increase in inlet 2 velocity resulted in a wider concentration profile of
the substrate (Figure 4-4A and B). As a result, the substrate's variable width above the
measuring junctions of the thermopile leads to an increase in the amount of heat that
dissipates to the reference junctions of the sensor. The heating of the reference junctions
leads to a decrease in the temperature difference and reduced voltage output of the
sensor. The optimal flow rates ratio of 1:4 (Figure 4-4C and D) ensures that the substrate
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was focused within the reaction zone and minimized the heat dissipation towards the
reference junctions of the sensor. In the experiments, the concentration of glucose was in
excess and was not a limiting factor for the enzymatic reaction.
4.3.2

Standard calibration curve
Synthetic TNF-α (0 pg mL-1, 125 pg mL-1, 250 pg mL-1, 1000 pg mL-1, and 2000

pg mL-1) was serially diluted and incubated with the anti-TNF-α capture and glucoseoxidase conjugated detection antibodies to generate the standard calibration curve.
Glucose was injected four times and the average area under the curve (AUC) of the
voltage signal was calculated for each TNF-α concentration (Table A 1 in Appendix).
The correlation coefficient (R) was estimated to be 0.9942 that indicates an excellent
correlation between the response of the microfluidic calorimetric immunosensor and the
concentration of the analyte (Figure 4-5A). The thermopile voltage increased as the
concentration of the cytokine increased. The thermoelectric response showed a linear
relationship with the TNF-α concentration in the range of 0 to 2000 pg mL-1. The
thermopile response for various concentrations of TNF-α is shown in Figure 4-5B. A
low-level signal was measured in the negative control experiments. It is hypothesized that
the thermopile responds to small temperature changes caused by the friction between the
buffers supplied by the inlets of the device.
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Figure 4-5: (A) Standard calibration curve for calorimetric microfluidic immunosensor.
(B) Thermopile voltage output for various concentrations of synthetic TNFα.83
The limit of detection (LOD) and limit of quantification (LOQ) of the calorimetric
immunosensor were estimated from the slope of the calibration curve (0.0315) and the
standard deviation of the blank (0.133) according to the following equations:
LOD=3.3*σ/S
LOQ=10*σ/S,

74
where σ is the standard deviation of the blank response and S is the slope of the
calibration curve. The LOD of the calorimetric immunosensor was 14 pg mL-1 and the
LOQ was 42 pg mL-1. The detection and quantification limits of the fabricated
microfluidic immunosensor are close to the values reported for the commercial
absorbance-based ELISA kit of 10 pg mL-1 and 30pg mL-1 respectively. The fabricated
calorimetric microfluidic immunosensor has a lower LOD than those of previously
reported fluorescent microfluidic sensors for quantification of TNF-α in serum (45 pg
mL-1) 35 and in cell culture medium (20 pg mL-1) 36.
4.3.3

Stability and reproducibility study
The storage stability at 4°C of the calorimetric biosensor was evaluated over two

weeks. The response to glucose (55mM) showed no changes in the average enzymatic
activity at the end of the period (Figure 4-6A).
Reproducibility analysis of within- and between assay variation was performed
using three immunosensing devices (250 pg mL-1 TNF-α). The coefficient of variation
between the assays was 0.99%. The intra-assay coefficient of variation for three different
devices was 0.72%, 0.24%, and 0.47% respectively (Table A 2 in Appendix). Potential
sources that add to the assay variation include minor differences in the Seebeck
coefficient of the thermoelectric sensor, the position of the antibody/analyte complex
within the junctions of the thermopile, as well as variations of the enzyme labeling
efficiency of the detection antibody.
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Figure 4-6: (A) Stability study for the developed calorimetric biosensor. (B) The
concentration of TNF-𝛼 in the cell culture medium of lipopolysaccharide
treated and non-treated human astrocytes were measured using conventional
microplate-based ELISA and calorimetric immunosensor (n=4).83
4.3.4

TNF-𝛼 concentration in cell culture medium
The feasibility of applying the sensor for analysis of biological samples was

investigated via quantification of TNF-α in cell culture media samples and comparison of
the levels measured using the microfluidic immunosensor and conventional ELISA. The
equation of the standard calibration curve was used to calculate the concentration of
TNF-α in the cell culture medium of non-treated and lipopolysaccharide (100 ng mL-1)
treated human astrocytes using the calorimetric technique. The levels of the cytokine
were measured using a conventional ELISA kit and the results were compared to assess
the accuracy of the microfluidic platform (Figure 4-6B). The concentration of TNF-𝛼 in
the cell culture medium of lipopolysaccharide treated and non-treated human astrocytes
were measured using conventional microplate-based ELISA and calorimetric
immunosensor (n=4). The concentration of TNF-α in lipopolysaccharide treated cells was
252 pg mL-1 and 251 pg mL-1 for absorbance ELISA and microfluidic immunosensor
respectively. The levels of TNF-α in non-treated astrocytes measured using conventional
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ELISA (170 pg mL-1) and the microfluidic device (169 pg mL-1) have less than 1%
variation. The developed biosensor exhibited good selectivity as TNF-α determinations
agreed well with the standard immunoassay analysis. The microfluidic immunosensor
had lower inter-assay variability in comparison to absorbance-based microplate
immunoassay. There was no significant difference between the results obtained by the
two methods and therefore the proposed immunosensor can be reasonably applied for the
analysis of biological samples.
4.4

Conclusion

This work describes the design, fabrication, and feasibility of a
calorimetric immunosensor that uses thin-film thermopile to accurately determine the
concentration of TNF-α in biological samples. The microfluidic device can detect low
levels of heat and utilizes a glucose oxidase conjugated antibody as a novel method for
sensitive detection of TNF-α. The assay is based on a sandwich-type immunoreaction
where the enzymatic reaction between the substrate and the enzyme generates heat that is
converted to an electrical signal by the sensor. The calorimetric immunosensor had a low
limit of detection of 9.88 pg mL-1. This novel calorimetric method for quantification of
TNF-α could be easily extended for sensitive detection of various analytes in biological
samples.

NUMERICAL OPTIMIZATION OF KEY DESIGN PARAMETERS
OF A THERMOELECTRIC MICROFLUIDIC SENSOR FOR
ULTRASENSITIVE DETECTION OF BIOCHEMICAL ANALYTES†

5.1

Background

Microfluidic technology enables rapid, sensitive, and accurate quantification and
detection of analytes 212. Microdevices are characterized by a large surface-to-volume
ratio that allows precise, fully automated fluidic control and capability for highthroughput analysis 213,214. Furthermore, lab-on-a-chip technology has reduced the cost of
biochemical analysis by more than 90% compared to the commercially available enzymebased quantification methods 215. The fabrication of highly sensitive microfluidic
platforms requires a detailed understanding of the interaction between fluid and
microchannel materials and the selection of design parameters that provide superior
accuracy, efficiency, and limit of detection 216,217. The complexity of the micro-and
nanoscale processes makes it difficult to experimentally investigate the impact of a single
mechanism. Therefore, numerical simulations enable the assessment of the effect of
single or multiple parameters on the performance of the platforms under study. Modeling

†

This chapter or portions thereof has been published previously in the ASME Journal of Thermal
Science and Engineering Applications under the title as it is in chapter title. Volume 13 (2021), DOI:
10.1115/1.4047826. The current version has been formatted for this dissertation.
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of the thermophysical characteristics of the system allows the selection of the optimal
design factors that provide enhanced performance

218,219

.

Calorimetric microfluidic platforms have been used for the detection of and
quantification of biochemical processes. An integrated thermoelectric sensor measures
the heat released during the enzymatic or chemical reaction and converts it to an electric
signal. This technology uses small sample volumes, provides quick response times, and
has a simplified detection approach. Due to the remarkable common-mode thermal noise
rejection capabilities, thin-film thermopiles are suitable for sensing very small
temperature changes 220. Moreover, calorimetry is compatible with most biochemical
processes as most of these reactions are exothermic or endothermic and are associated
with temperature change. Microscale thermoelectric devices have been employed to
measure temperatures in the range of mK-µK for characterization of the thermodynamic
properties of biomolecules 221 and metabolites measurement 222. Thermoelectric sensors
have been successfully used for quantification of TNF-α 83, modified nucleobases 214,
monitoring the metabolic rate of bacteria 41, detection of enzymatic reactions 44,
measurement of DNA and protein binding affinity 45, detection of nucleotide
incorporation 43, and DNA hybridization events 223. Because the calorimetric detection
method is universal, it can be applied for assays that cannot be performed using other
techniques 224.
Microfluidic calorimeters are characterized by large surface-to-volume ratios and
have increased heat and mass transfer efficiencies. However, the suitability of ultra-low
sample volume thermoelectric sensors suffers from their low volume-specific sensitivity.
A central challenge in using microfluidic systems for thermoelectric measurements is
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optimizing the design parameters of the device that includes flow rate, sample volume,
and microchannel material properties to increase the sensitivity and specificity of the
platform 225. Parasitic heat transfer in microcalorimetry results in heat loss to the substrate
that decreased the overall heat transfer to the thermoelectric sensor. Numerical and
experimental analysis using a glass fabricated device confirmed that depositing the
thermopile sensor directly on a lower channel wall decreases the thermal resistance
between the heat source and thermopile and increases the rate of heat transfer per
temperature change by 6.5 times 226. The effect of thermal asymmetry on thermopile
sensitivity was modeled and experimentally validated. The results from this study suggest
that there is an optimal thermopile position within the microchannel and this position is
influenced by the flow ratio 227. Numerical simulations indicated that a decrease in signalto-noise ratio with increasing chamber height is caused by the changes in the sensitivity
gradient inside the reaction chamber 228. A microfluidic calorimeter with an integrated
thermopile was modeled to investigate the effect of flow rates on glucose oxidase
enzymatic reaction. This study confirmed that flow rates were inversely related to
convective heat loss and, therefore, reduced the thermopile response 229. The relationship
between the fluid velocity, sample volume, and the signal output in a thermoelectric
microfluidic device was analyzed. Results indicated that the signal duration and
magnitude had an inverse relation with the fluid flow rate. As fluid velocity increases, the
ratio of convective heat loss to conductive heat transfer towards the measuring junction
of the sensor increased. Since more of the generated heat is lost to the moving fluid, the
maximum temperature over the measuring junctions is decreased 220.
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In this chapter, a detailed, three-dimensional numerical modeling of a continuousflow microfluidic thermoelectric biosensor is presented. The critical design parameters
that provide the maximum signal output are discussed. The governing equations for the
numerical analysis and the design of the device are presented and the simulation results
were compared with the experimental measurements that were recently published 83 and
reported in CHAPTER 4. The cumulative effect of multiple factors on the heat
distribution within the microchannel and the rate of heat transfer to the sensor were
simulated using the “laminar flow”, “transport of the diluted species”, and “heat transfer”
modules in COMSOL Multiphysics 5.4. Conjugate heat transfer analysis was performed
to identify the optimal parameter combination that provides maximum sensitivity. The
factors that heavily determine the performance characteristics of the thermal microfluidic
device include channel height, physical properties of the device materials, inlets flow
rates ratio, and the presence of a heat sink in contact with the reference junctions of the
thermopile.
5.2
5.2.1

Methodology

Numerical simulations
The microfluidic continuous-flow thermal sensing platform, the thermopile, and

the aluminum holder used as a heat sink are shown in Figure 5-1. The device had two
inlets and a single outlet. The reaction zone for the enzymatic reaction between glucose
and glucose oxidase was positioned directly above the measuring junctions of the thinfilm antimony-bismuth (Sb-Bi) thermopile. Water flow was simulated in inlet 1 while a
13µL glucose bolus injection (55mM) was simulated in inlet 2 (Figure 5-1a). In this
numerical model, water was used as a replacement of phosphate buffer solution pumped
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through inlet 1, which was used for the experiments, due to the similarities in fluid
properties. The chemical reagents are transported in the microfluidic device via the
motion of fluids that can be efficiently controlled by flow-focusing inside the
microchannel. The inlet 2 flow rate affects the sample transient time and the duration of
the signal, while the fluid velocity ratio between the two inlets focuses the glucose stream
hydrodynamically over the measuring junctions of the thermopile. The enzyme (glucose
oxidase) that defines the reaction zone (8mm×3mm) is positioned on the inner surface of
the lower channel wall directly above the measuring junctions of the sensor. The
substrate (glucose) was introduced through inlet 2 and hydrodynamically focused to flow
over the measuring junctions of the sensor. The enzymatic reaction occurs when the
substrate reaches the enzyme-defined reaction zone. The thickness of the upper channel
wall was 1 mm, and the thickness of the lower channel wall was 175μm. The
thermoelectric sensor (8mm×8mm×100µm) had 60 thermocouple junctions and a
theoretical Seebeck coefficient of 7.14µV mK-1 (Figure 5-1a).
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Figure 5-1: (a) Schematic of the microfluidic device with an integrated thermoelectric
sensor. Hydrodynamically focused glucose introduced through Inlet 2 flows
directly above the measuring junctions of the sensor. (b) Schematic of the
aluminum holder. The reference junctions of the thermopile are in contact
with the aluminum block that serves as a heat sink while the measuring
junctions of the thermopile and the reaction zone are position directly above
the air gap. 230
The thermopile was positioned to the outer surface of the lower channel wall.
The measuring junctions of the thermopile are located underneath the reaction zone and
the hydrodynamically focused glucose stream provided by inlet 2. The reference
junctions of the sensor were positioned below the water stream supplied by inlet 1. The
design of the device and the thermopile ensures that the heat generated by the enzymatic
reaction is transferred through the lower channel wall to the thermopile measuring
junctions by conductive heat transfer. When the heat reaches the thermopile, the
temperature of the measuring junctions increases relative to that of the reference
junctions and generates a Seebeck voltage.
Two categories of simulations were performed: one where the reference junctions
were in contact with a heat sink that maintained a constant temperature of 293.15 K, and
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one simulation without a heat sink. A schematic diagram of the aluminum heat sink is
shown in Figure 5-1b. While the heat sink maintains a constant temperature at the
reference junctions, it also absorbs the heat that dissipated from the reaction zone and
impacts the magnitude of the thermoelectric output of the sensor. The heat released by
the enzymatic reaction increased the temperature of the measuring junctions relative to
the reference junctions. The temperature difference between the junction sets was
converted to a voltage by the thermopile. The theoretical voltage output was determined
using the simulated temperature difference and the theoretical Seebeck coefficient of the
thermopile.
COMSOL Multiphysics 5.4 was used to solve continuity, Navier-Stokes, and
energy equations for both fluid and solid subdomains simultaneously. The enzymatic
reaction between glucose oxidase conjugated detection antibodies and glucose occurred
within the reaction zone and generated heat. Therefore, the heat source for the study was
a function of the glucose oxidase and glucose concentrations, the reaction rate constant,
and the rate of heat generation. A summary of the parameters’ nomenclature used in the
governing equations is given in Table A 4 in the Appendix. The values of the
parameters used in the equations are listed in Table A 3 and the characteristic material
properties are included in Table A 5.
The time-dependent simulations of the temperature distribution and glucose
profile were performed for 240 seconds. A step function was used to increase the glucose
concentration at t=0 to 55mM followed by a step down to cg=0 concentration after 13µL
was introduced into the inlet 1 fluid stream. The inner surface of the microchannel was
modeled with non-slip boundary conditions according to the continuum assumption
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applicable for microscale fluid flow. The “laminar flow” module was conjugated with the
“transport of diluted species” and “heat transfer” modules in COMSOL. The “transport of
diluted species” module was used to simulate the flow of glucose within the
microchannel. The “heat transfer” module was used to calculate the temperature
difference between the measuring junctions and the reference junctions of the thermopile.
The working fluid, water, was assumed to be incompressible, and continuum flow
(Knudsen number < 10-3) of the fluid was considered. Therefore, the Navier-Stokes
equation and the continuity equation were solved with the laminar flow interface. To
account for the conservation of momentum and conservation of mass, it was assumed that
the device was perfectly insulated. The governing equations (Navier-Stokes and
continuity, respectively) for fluid flow are as follows:
𝜌𝑓

𝜕𝑢
𝜕𝑡

+ 𝜌𝑓 𝑈 ∙ 𝛻(𝑈) = −𝛻𝑝 + 𝛻 ∙ [𝜇(𝛻𝑈 + 𝛻𝑈 𝑇 )] + 𝐹𝑏

𝛻∙𝑈 = 0

(Eq. 3-1)
(Eq. 3-2)

The fluid velocity at the inlets was set to be a non-zero value to drive the fluid
inside the microchannel according to the following equation:
𝑢𝑖𝑛 =

𝑢𝑚
𝜌𝑓

(Eq. 3-3)

The outlet of the device was maintained at atmospheric pressure (𝑝 = 0):
𝑝𝑜𝑢𝑡 = 0

(Eq. 3-4)

The diffusion flux of the diluted species was included with the convective flux
due to the bulk fluid motion inside the microchannel. Therefore, diffusive and convective
mass transports were considered to account for the flow of glucose inside the
microchannel:
𝜕𝑐𝑔
𝜕𝑡

= 𝛻 ∙ (𝐷𝑔 𝑐𝑔 ) − 𝑈 ∙ 𝛻𝑐𝑔

(Eq. 3-5)
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The device was modeled as perfectly insulated and the rate of thermal radiation
was assumed to be negligible. According to the first law of thermodynamics, the equation
for conservation of total internal energy of an infinitesimal volume of fluid was expressed
as:
𝜕

1

𝜕𝑡

1

[𝜌 (∆𝐸 + 2 𝑢2 )] + 𝛻 ∙ [𝜌𝑈 (∆𝐸 + 2 𝑢2 )] = −𝛻 ∙ 𝑞 + 𝛻 ∙ (𝜎 ∙ 𝑈) + 𝜌𝑈 ∙ 𝐹𝑏
(Eq. 3-6)

The rate of change in energy per unit volume and the convection of energy due to
fluid flow was defined on the left side of the equation. The total heat flux, the work done
by the surface forces, and the total work done by the body forces were defined on the
right side of the equation. Expressing the total stress tensor, σ, in terms of pressure (𝑝)
and the viscous stress tensor (τ), were obtained as follows:
𝛻 ∙ (𝜎 ∙ 𝑈) = −𝛻 ∙ (𝑝𝑈) + 𝛻 ∙ (𝜏𝑈)

(Eq. 3-7)

Substituting the value for the work done due to the surface forces in Eq. 3-6
yields:
𝜕

1

𝜕𝑡

1

[(𝜌 2 𝑢2 )] + 𝛻 ∙ [(𝜌𝑈 2 𝑢2 )] = −𝛻 ∙ 𝑞 + 𝑈(𝛻 ∙ 𝑝) + 𝑈 ∙ (𝛻 ∙ 𝜏) + 𝜌𝑈 ∙ 𝐹𝑏
(Eq. 3-8)

Eq. 3-8 can be expressed in terms of enthalpy according to the following
equation:
𝜕ℎ

𝜕𝜌

𝜌 𝜕𝑡 + 𝜌𝑈 ∙ 𝛻ℎ = −𝛻 ∙ 𝑞 + 𝑈 ∙ 𝛻𝑝 + 𝜕𝑡 + 𝜏 ∙ 𝛻𝑈 + 𝑄

(Eq. 3-9)

The heat source was defined as a function of the reaction rate constant, the
concentration of glucose and glucose oxidase within the reaction zone, and the reaction
energy.
𝑄 = 𝑘𝑔 × 𝑐𝐺𝑜𝑥 × 𝑐𝑔 × 𝐸𝑔

(Eq. 3-10)
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The conduction heat flux vector, q, was defined from Fourier’s conduction law as:
𝑞 = −𝑘𝛻𝑇

(Eq. 3-11)

The conservation of the enthalpy equation was expressed in terms of temperature,
T, and pressure, p as follows:
1

𝑑ℎ = 𝑐𝑝 𝑑𝑇 + 𝜌 [1 − 𝑇𝛽]𝑑𝑝

(Eq. 3-12)

Replacing the enthalpy value in Eq. 3-9 yields the temperature equation as:
𝜕𝑇

𝜕𝑝

𝜌𝑐𝑝 𝜕𝑡 + 𝜌𝑐𝑝 𝑈 ∙ 𝛻𝑇 = 𝛻 ∙ (𝑘𝛻𝑇) + 𝛽𝑇 ( 𝜕𝑡 + 𝑈 ∙ 𝛻𝑝) + 𝜏 ∙ 𝛻𝑈 + 𝑄
(Eq. 3-13)
Since the working fluid was assumed to be incompressible, the pressure term in
Eq. 3-13 can be eliminated. Considering this condition, the equation for temperature was
finally simplified to:
𝜕𝑇

𝜌𝑐𝑝 𝜕𝑡 + 𝜌𝑐𝑝 𝑈 ∙ 𝛻𝑇 = 𝛻 ∙ (𝑘𝛻𝑇) + 𝜏 ∙ 𝛻𝑈 + 𝑄

(Eq. 3-14)

The simulations were performed for 13 µL of 55 mM glucose that was introduced
through inlet 2 while inlet 1 carried a water solution. The temperature difference between
the measuring and reference junctions was converted to a voltage output using the
theoretical Seebeck coefficient value of the antimony-bismuth (Sb-Bi) thermopile sensors
(𝛼 = 7.14µV mK-1) according to the following equation:
∆𝑉 = 𝛼∆𝑇

(Eq. 3-15)

A step function that describes the glucose concertation was defined to ensure that
the flow of glucose stopped after the sample was introduced in the microfluidic channel,
at which point a glucose-free water solution continued to be injected into inlet 2 using the
same flow rate as the glucose stream, similar to the bolus injection used in the actual
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experimental procedure. This was done to ensure that the accuracy of the model can be
evaluated, and the simulation results can be compared with the experimental values. A
parametric sweep was performed for a comparative analysis of the various parameters.
5.2.2

Experimental set up for thermoelectric biosensor
The integration of the microfluidic device with a fluid delivery platform and the

data acquisition system was described in a previously published work. The microfluidic
thermoelectric platform was successfully used for accurate quantification of TNF-α
concentration 83. Briefly, the detection antibody was conjugated to glucose oxidase and
the antibody-analyte complex was immobilized at the inner surface of the lower channel
wall, directly above the measuring junctions of the thermopile sensor. Glucose (55mM)
was injected through a 13µL sample loop into the inlet 2 fluid stream and was converted
by the enzyme to gluconic acid and hydrogen peroxide. The enzymatic reaction generates
heat at a rate of 79 kJ mol-1 209:
𝑮𝒍𝒖𝒄𝒐𝒔𝒆 𝑶𝒙𝒊𝒅𝒂𝒔𝒆

Glucose + O2 + H2O →

𝒌𝑱

Gluconic acid + H2O2 + 79 𝒎𝒐𝒍

The flow rate for inlet 1 (water) and inlet 2 (glucose) were 100µL min-1 and 25µL
min-1, respectively. The reference junctions of the sensor were maintained in contact with
an aluminum heat sink to maintain a constant temperature. The heat of the enzymatic
reaction increased the temperature of the measuring junctions relative to the reference
ones. The thermopile converted the temperature difference into an electric signal that was
recorded by a nanovolt meter.

88
5.3
5.3.1

Results and discussions

Experimental validation of the numerical model
Experimental study 83 was used to verify the proposed three-dimensional

numerical model for time-dependent analyses of temperature distribution within the
microchannel of the device. The simulation results indicated an excellent correlation with
the experimental data in predicting the maximum voltage output. The microfluidic
channel had a rectangular cross-section (65mm×12mm) and was fabricated using rapid
prototyping by sandwiching a patterned adhesive tape between the upper and lower
channel walls. A thin-film thermopile was attached to the outer surface of the lower
channel wall and the reference junctions of the device were maintained in contact with an
aluminum heat sink. Both the experimental and the theoretical analyses were performed
in a device that had upper (75mm×25mm×1 mm) and lower (75mm×25mm×170 µm)
walls formed out of glass material. The device had 2 inlets and a single outlet. The
microfluidic channel height was 100 µm and 13 µL of glucose (55mM) was introduced
through inlet 2. A phosphate-buffer saline solution was introduced through inlet 1 and
inlet 2 after the glucose bolus injection.
The pattern of fluid flow inside the microchannel is determined using a
dimensionless constant, Reynolds number. Examining the velocity profiles for the
various cases studied the maximum velocity in the microfluidic channel was 10 mm sec-1
corresponding to local Reynolds number of 10-4 indicating a laminar flow. The
simulations and the experimental studies were performed for a total of 240 seconds to
allow for the heat within the reaction zone to dissipate and the signal to return to a
baseline level. The time-dependent concentration of glucose within the microchannel was

89
assessed on the bottom of the channel (XY-plane) at 0, 40, 80, and 120 seconds after the
injection of glucose (Figure 5-2). The maximum thermopile output in the experimental
results is reached 80 seconds from the injection of the substrate within the fluid flow.

Figure 5-2: Glucose concentration profiles and locations of the bolus injection relative to
the reaction zone at 0, 40, 80, and 120 seconds. The fluid flow rates for inlet
1 and inlet 2 were 100µL min-1 and 25µL min-1, respectively.230
The theoretical voltage output of the sensor reached a maximum value of 1.66µV
at 80 seconds after the injection of the glucose in the channel of the device. The
experimental value of the thermopile response obtained using the same parameters was
1.67μV. The numerical simulations show a good correlation between the simulated and
experimental position of the glucose flow relative to the reaction zone (Figure 5-3). The
predicted and the experimental values for the peak height and signal duration are in close
agreement. The standard error of the area under the curve for the experimental
measurements was less than 1% of the signal response. The average temperature change
derived from the Seebeck coefficient, and the voltage output of the sensors was
0.26mK83.
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Figure 5-3: A comparison between the numerical and experimental voltage signal of the
thermopile sensor. The upper and lower channel walls of the device were
fabricated out of glass. The fluid flow rates for inlet 1 and inlet 2 were 100µL
min-1 and 25µL min-1, respectively.230
The model considers that the enzymatic reaction occurs within the fluid directly
above the measuring junctions of the thermopile sensor. By controlling the ratio of the
flow rates of the two inlets, the second inlet (i.e., the middle flow) can be
hydrodynamically focused to flow directly over the measuring junctions. Since the
glucose is only present as bolus injection in the second inlet, the chemical reaction
between the glucose and glucose-oxidase bound-antibodies only occurs over the
measuring junctions. Likewise, the outer flow over the reference junctions provided
sufficient convective heat transfer to keep the reference junction at a constant temperature
(i.e., room temperature of the water in the device). The experimental studies were
performed at the surface of the lower channel wall. The enzyme was immobilized directly
above the thermoelectric sensor and the substrate was introduced within the fluid flow. In
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the experimental studies, a solution containing the glucose-oxidase conjugated antibodies
is immobilized to the glass channel wall directly above the measuring junctions of the
thermopile (i.e., the middle of the thermopile). The sensor is attached to the opposite
(flipped) side of the lower channel wall 83. The mathematical model replicates the
environment by applying an exothermic reaction condition on a designated surface on the
inner side of the bottom channel surface directly above the measuring junctions of the
thermopile. The hydrodynamically focused flow carrying the substrate (as mentioned
previously) maintains the width of the reaction zone constant over the measuring
junctions. It is noted that the designated “reaction zone” used in the model is wider than
the hydrodynamically focused flow (in all cases studied) so that an inaccurate forced
condition is not present in the experimental study would not affect the results. This
accounted for the increased width of the experimental signal relative to the simulated
results. The developed 3D model was subsequently used for investigating the impact of
the channel height, fluid velocity, physical properties of the device material, and heat sink
on the thermopile output.
A time-step independence study was conducted with time-steps varying from
0.25sec to 5sec over a window between 0 and 240sec. The time-step independence study
shows that for a time-step of 1sec (the value used for this study which provides an
excellent correlation in finding the peak voltage difference) a peak voltage difference
value is obtained that diverges from the converged value (seen at the smaller time steps)
by less than 1% by reducing the simulation time by more than half. An increase in the
time step from 0.25s to 5s results in increasing the peak voltage value by 2.8%.
Therefore, the choice of the time step as 1sec for this study is justified as it provides an
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accurate correlation with the experimental study and at the same time requires a
reasonable amount of simulation time. The model understudy incorporated a physicscontrolled finer mesh specifically around the physics modeled in this study and the
Multiphysics tools used to create the model simulations (laminar fluid flow, mass
transport of diluted species, and heat transfer in a fluid/solid). Because of this, the
software automatically selects tighter meshes (i.e., smaller elements) in areas where a
higher resolution is needed (e.g., entrance and exit effects of fluid flow, regions where
exothermic reactions occurred, etc.).
5.3.2

Effect of microfluidics channel height
The simulation analysis of the effect of channel thickness (50 µm, 100 µm,

150µm, and 200 µm) was performed for a microfluidic device that had upper and lower
channel walls formed of glass. The flow rate for inlets 1 and 2 was 100µL min-1 and
25µL min-1 respectively. An increase in the channel height from 50µm to 200µm resulted
in a decrease of the predicted signal from 2.45µV to 0.73µV. An increase in channel
height affected the thermopile voltage output signal in two ways: by lowering the
amplitude of the signal and by increasing the duration (i.e., width) of the signal response.
This study assesses the impact of the parameters that will maximize the area under the
curve (AUC) of the voltage signal. The two effects on the voltage signal that varying the
channel height have opposed each other; a decrease in the amplitude would result in a
lower AUC, whereas an increase in the signal duration would increase the AUC. Through
the analyses of the numerical model, it was determined that the loss in AUC from a
decrease in the signal amplitude exceeds any gains brought on by the increase in signal
duration. Because of this, the primary focus of this study was to analyze the signal
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amplitude as the desired metric to optimize. The increase of the channel height results in
a larger cross-sectional surface area that leads to a reduced velocity of the glucose
solution inside the reaction zone. This contributes to a longer response time of the
thermopile sensor with a decrease in the magnitude of the voltage output (Figure 5-4).
Additionally, the decrease of the channel height reduces the residence time of the heat
within the reaction zone and decreases the rate of lateral heat dissipation from the
measuring junctions towards the reference junctions of the thermal sensor. Therefore, the
thermoelectric voltage is increased.
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Figure 5-4: Mathematical simulations of thermopile voltage output as a function of
microfluidic channel height (Tc). The upper and lower channel walls of the
device were fabricated out of glass. The fluid flow rates for inlet 1 and inlet 2
were 100µL min-1 and 25µL min-1, respectively.230
5.3.3

Effect of inlets flow rate ratio
The optimal fluid flow rate ratio between inlet 1 and inlet 2 ensures that the fluid

introduced at inlet 2 (glucose) is hydrodynamically focused within the reaction zone just
above the measuring junctions of the thermopile. Color-dye experiments indicated that
the width of the inlet 2 flow is affected by the flow rate ratio between inlet 1 and inlet 2.
These experimental results confirmed that the width of the glucose stream increased from
3mm to 4mm as the fluid flow rate ratio between inlet 1 and inlet 2 decreased from 4:1 to
2:1 (data not shown). Numerical simulations were performed to analyze the change in the
duration and magnitude of the thermopile output as a function of the fluid velocity
between inlet 1 and inlet 2. Inlet 1 flow rate was maintained constant at 100µL min-1
while the flow rate of inlet 2 was reduced from 50µL min-1 to 25µL min-1. An increase in
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the flow rate increased the sample’s transient time to the reaction zone. The changes in
the width of the reaction area impact the distance between the enzymatic reaction (heat
source) and the reference junctions of the thermopile that are in contact with the heat
sink. Therefore, reducing the lateral thermal diffusion affected the amount of heat that
dissipated to the reference junctions. A decrease in the thermal difference between the
junction sets causes a reduction in the voltage (Figure 5-5).

Figure 5-5: Numerical analysis of the effect of inlet flow rate ratio on the thermopile
voltage output. The channel height was 100µm and the upper and lower
channel walls were formed out of glass.230
5.3.4

The relationship between material thermal properties, heat sink, and

thermoelectric signal
A numerical analysis was performed to investigate the impact of material thermal
properties on the magnitude of the thermoelectric voltage output. The simulations were
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performed for a device that had a channel height of 50 µm and upper and lower wall
thicknesses of 1mm and 170 μm, respectively. The mathematical analysis of heat transfer
was performed using the following combinations of materials for the upper and lower
channel wall: glass, polydimethylsiloxane (PDMS), and polymethyl methacrylate
(PMMA). To understand the impact of keeping the reference junctions of the sensor
under temperature control and in contact with an aluminum block, the thermal difference
between the junctions of the sensor was analyzed with and without a heat sink. When the
reference junctions of the sensor are maintained under constant temperature control, the
heat that dissipates laterally from the reaction zone is transferred towards and absorbed
by the aluminum heat sink. Adding a heat sink in contact with the reference junctions of
the sensor ensures that the reference junctions are kept at a constant temperature.
However, the results indicate that keeping the reference junctions of the sensor in contact
with a heat sink results in lower average temperatures difference between the junction
sets of the sensor that reduces the sensitivity of the calorimeter (Figure 5-6 and Figure
A 1).
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Figure 5-6: Mathematical simulation of the temperature outputs at the (a) reference
junctions and (b) measuring junctions of the thermopile in the presence and
absence of aluminum heat sink. Channel height 100µm, upper and lower
channel wall fabricates out of glass.230
The design of the microfluidics device minimized the ambient temperature
distortions by positioning both junctions of the sensor in a single flow-through channel.
These factors ensure controlled symmetry of heat generation and reduce the artifacts of
the measured signals in the absence of heat sink.
The thermal conductivity, thermal capacity, and thermal diffusivity of the
materials have a significant impact on the magnitude of the thermoelectric signal.
Mathematical analysis was performed using five different device configurations where
the upper channel wall was fabricated out of PMMA, PDMS, or glass while the lower
channel was fabricated out of glass (PDMS-glass; PMMA-glass, glass-glass), PDMS
(PDMS-PDMS), or PMMS (PMMA-PMMA). Mathematical analysis indicated that the
highest voltage output of 13.2µV is obtained for a device with upper and lower channel
walls fabricated out of PDMS and without a heat sink. The glass channel walls
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configuration coupled with an aluminum heat sink generates the lowest voltage output of
1.66µV (Figure 5-7).
Glass has a higher thermal conductivity and diffusivity (0.49mm2 sec-1 231)
relative to that of PDMS (0.11 mm2 sec-1 232) that leads to the rapid dissipation of the heat
in x and y directions. Both PMMA and PDMS materials have higher specific heat
capacities that lead to an increase in the temperature difference between the junctions of
the sensor. Videos of the heat dissipation for the enzymatic reactions for each material
configuration are included in the supplementary information (S4). While PDMS can offer
increased sensitivity for calorimetric detection of analytes, the material also has
drawbacks that need to be considered for this particular application. It has been reported
that PDMS surfaces absorb proteins and small hydrophobic molecules 233 and the
polymer is susceptible to swelling and shrinking with commonly used chemicals 234. In
microfluidic devices with a low aspect ratio (height to width), the elastic deformation of
the PDMS microchannel can affect the laminar flow profile and pressure distribution
within channel 235. These particular chemical and mechanical properties were not
incorporated into this computational study.
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Figure 5-7: Numerical simulation of voltage output as a function of material type. The
channel height was 50µm. The fluid flow rates for inlet 1 and inlet 2 were
100µL min-1 and 25µL min-1, respectively. (a) Thermopile reference junctions
at ambient temperature. (b) Thermopile reference junctions in contact with a
heat sink.230
All of these results are of particular interest to identify the type of material that
provides the maximum thermal detection sensitivity. Although glass has a high thermal
conductivity the benefits are reduced by the increased rate of lateral heat dissipation from
the measuring to the reference junctions of the sensor that reduces the thermal difference
between the thermocouple sets. This hypothesis is validated by performing a 2D analysis
that neglects the lateral heat dissipation and considers that the reference junctions are
maintained at a constant temperature while in contact with a heat sink. The 2D model
provides a maximum signal output 30 seconds after glucose is introduced inside the
fluidic channel. According to the results obtained, the voltage output decreases by 5.5%
for glass-PDMS orientation and 61.4% for PDMS-PDMS after 30 seconds relative to
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glass-glass orientation with the same geometry and boundary conditions Figure 5-8. This
occurs due to the lower thermal conductivity of PDMS compared to glass.

Figure 5-8: Effect of substrate material on voltage output obtained using the 2-D model
and neglecting the lateral heat dissipation.
However, this 2D model does not account for the thermal diffusivity along the
width of the device, which is a crucial factor for the identification of the device materials
combination. According to the 3D model, the signal output for a device fabricated out of
glass (lower wall) and PDMS (upper wall) is 5.08µV while the signal increases to
9.27µV for a PDMS-PDMS device (with a heat sink present). PDMS is not only a better
substrate for the fabrication of the lower channel wall, but it significantly improves the
sensitivity of the platform when used as an upper wall material by reducing the rate of
heat loss.
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5.4

Conclusion

The scope of this work has been to identify the critical operational parameters to
enhance the sensitivity of the microfluidic thermal sensor. Numerical simulations were
performed to investigate the effect of channel height, volumetric flow ratio, and material
thermal properties on the temperature distribution and signal output for the platform. The
work has relied on both experimental data and numerical analyses that show excellent
correlation. The temperature difference detected by the thermopile’s junctions depends
on the thermal properties of the materials, the presence of a heat sink underneath the
reference junctions of the sensor, the flow rate, and the dimensions of the channel. The
magnitude of the thermoelectric signal is inversely proportional to the height of the
channel and fluid velocity. Using materials with a lower thermal conductivity and
eliminating the heat sink can be leveraged to maximize the temperature difference
between the thermopile junction sets. This is an exciting hypothesis because theoretically,
a material with higher thermal conductivity (glass) should be an ideal substrate compared
to a lower thermal conductive material (PDMS) as the application is based on
thermoelectric signal measurements. But the 3D model shows that higher lateral thermal
diffusivity of glass compared to PDMS acts against the conventional prediction.
Experiments are suggested as future works to validate the results obtained using the 3D
model to confirm the best combination of materials for the device fabrication predicted
by the numerical model.

NUMERICAL ANALYSIS OF OPTIMAL DESIGN PARAMETERS
FOR A CELL CO-CULTURE
MICROFLUIDIC PLATFORM WITH AN INTEGRATED
PRESSURE-CONTROLLED VALVE†

6.1

Background

The development of microfluidic technology for the analysis of cell-to-cell and
cell-extracellular matrix interactions is an important topic in biomedical engineering
research. While conventional cell co-culture approaches, such as transwell-type coculture plates, are successfully used for functional analysis of cell-to-cell
communications, this technology does not permit a controlled exchange of fluids between
two cell culture chambers 55. Lab-on-a-chip platforms enable a real-time, on-chip analysis
of the interaction between cells and their microenvironments. Microfluidics provides
flexibility in the device design and better control of the experimental conditions that
facilitate drug discovery studies 56.
Cell co-culture microdevices with an integrated valve enable precise control of
the exchange of biochemical factors while minimizing sample variability and enhancing
the sensitivity of the analysis 57. Cell co-culture microfluidic platform has been
successfully used for the enhancement of the transfection efficiency of neurons and glia
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compared to the conventional petri dish. Polydimethylsiloxane (PDMS) pressure-driven
valve fabricated via soft-lithography provided a reversible control and separation of the
two cell chambers 236. A microdevice with a hydraulically controlled PDMS valve was
used for the assessment of the interaction between tumor and endothelial cells. On-chip
co-culture of multiple cell types of the intestine, liver, and glioblastoma equivalents was
used for the analysis of drug absorbance and toxicity 237.
Although multiple studies are reporting the design and fabrication of microfluidic
cell co-culture platforms, very few research groups developed numerical models to
investigate the impact of physical parameters (e.g., valve thickness, material elasticity,
pressure) on the optimal design of the device. A three-dimensional numerical flow model
of cell co-culture was developed to analyze the species concentration within the
microchannel. The study indicates that the distribution is a function of channel length and
inlet concentration 238. Numerical analyses were performed to determine the displacement
of the micropillars in a cell co-culture platform. The mathematical simulations indicated
that the gap, size, velocity, and height of the micropillar modules had a substantial impact
on the stability of the arrays 239.
The rapid development of 3D printing and rapid-prototyping microfabrication
techniques enables the fabrication of lab-on-a-chip platforms for cell co-culture. These
devices can provide precise control of fluid dynamics and environmental factors. In this
paper, we report the fabrication and optimization of critical design parameters of a
microfluidic device with an integrated PDMS hydraulic valve that reversibly separates
two cell culture chambers. A two-dimensional numerical analysis of factors that affect
the deflection of a valve was performed, and the optimal combination of optimized
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parameters for effective isolation of two chambers is presented. The parameters under
investigation include water height, membrane thickness, and the elasticity of the PDMS.
The proposed microfluidics platform is innovative because it could enable the
controlled exchange of released cell signaling molecules between two cell lines as well as
the integration of a microprobe-based method for the purification of mRNA 240. The
proposed microfluidics platform offers a promising new tool for the assessment and
characterization of the complex interaction of different cell types.
6.2
6.2.1

Materials and methodology

Device design
The platform understudy consists of two 27.5 mm × 35 mm × 10 mm cell culture

chambers separated by a PDMS-fabricated hydraulic valve (10 mm × 35 mm × 9.5 mm).
The actuation of the valve is controlled using hydraulic pressure exerted by the chamber
positioned directly above the valve. The deflection of the valve barrier provides
separation of the cell chambers and the individual microenvironments. Upon the release
of the pressure, the valve returns to its original position and allows the exchange of
signaling molecules between the cells (Figure 6-1).
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Figure 6-1: Design of microfluidics cell co-culture platform. Pressure controlled valve
separates the cell chambers (A). Upon release of the pressure, the valve
moved to a vertical position and allows the exchange of signaling molecules
between the cell lines.241
6.2.2

Numerical modeling
The impact of several factors on the vertical displacement of the valve was

mathematically simulated using COMSOL Multiphysics 5.4. The software implemented
the Mooney-Rivlin method, a widely used hyper-elastic material model due to the choice
of fabricating a PDMS-based valve 242. A schematic of the device, including the
dimensions of the pressure-controlled valve is shown in Figure 6-2. The two-dimensional
numerical model was developed in XZ-plane. The width of the device (along XY-plane)
is not considered since the analysis is focused on the displacement of the valve in a
vertical direction. The bottom channel wall is a glass slide (75 mm × 35 mm × 18 mm),
while the pressure chamber and the hydraulic valve are filled with water to actuate its
displacement.
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Figure 6-2: (a) Schematic of the components of the cell co-culture device. (A) hydraulic
pressure chamber, (B) PDMS valve, (C) channel wall, and (D) glass; (b)
Schematic and dimensions of hydraulic valve.241
The height of the hydraulic pressure chamber provides the force that bends the
PDMS and displaces the valve in the vertical direction to close the barrier between the
cell chambers. The distance between the valve and the lower channel wall is 1mm, while
the distance between the maximum elevation of the valve and the glass slide is 0.5 mm.
The width of the valve and the pressure chamber is 10 mm is considered as an open
boundary for the simulations.
The Fluid-Structure Interaction (FSI) multiphysics interface combines fluid flow
with solid mechanics to capture the interaction between the fluid and the solid structure.
A solid mechanics interface and a single-phase flow interface model the solid and the
fluid, respectively. The FSI module combines the pressure exerted by water inside the
pressure chamber using the laminar flow interface with the displacement of the valve due
to the hydrostatic pressure using the solid mechanics interface. The FSI couplings appear
on the boundaries between the fluid and the solid. The deflection of the valve due to the
hydraulic pressure is modeled using the arbitrary Lagrangian-Eulerian method (ALE). As
for loading, the outer surfaces of the device were fixed. The internal surfaces were free to
deform due to the hydrostatic pressure present. However, only the flexible membrane was
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thin enough to demonstrate noticeable deflections. The vertical walls of the chamber
holding the water that would cause the valve to close experienced some deflections, but it
was significantly less than the deflection observed by the membrane.
The working fluid is assumed to be incompressible. Therefore, the Navier-Stokes
equation and the continuity equation are solved. Navier-Stokes equation using arbitrary
Lagrangian-Eulerian formulation for an incompressible fluid is defined by:
𝜕𝑢𝑓

𝜌𝑓

𝜕𝑡

+ (𝜌𝑓 ∙ ∇𝑢𝑓 ∙ 𝑢𝑐 ) + ∇𝑃 − (2𝜇∇𝜀) = 𝜌𝑓 𝐹𝑓𝑏

𝛻 ∙ 𝑢𝑓 = 0

(Eq. 4-1)
(Eq. 4-2)

The model considers a low viscosity fluid (𝜇 = 0) in the pressure chamber, and
the walls of the device are considered to be in no-slip condition. The impact of
gravitational force on the displacement of the valve is considered as well. The actuation
of the valve caused by hydraulic pressure is governed by the following equation:
𝜕2𝐿

𝜌𝑠 𝜕𝑡 2 − ∇ ∙ [𝐹𝑠 ∙ 𝑆𝑠 ] = 𝜌𝑠 𝐹𝑠𝑏

(Eq. 4-3)

Both the working fluid and membrane of the valve are fully coupled at the
interface of interaction, Γ, to consider for both dynamic and kinematic continuity, which
is a prime coupling condition. Therefore, the coupling equations for kinematic continuity
is defined as:
𝑓

𝐿Γ (𝑡) = 𝑥Γ (𝑡)

(Eq. 4-4)

𝐿𝛤̇ (𝑡) = 𝑢𝑓 Γ (𝑡)

(Eq. 4-5)

𝐿Γ̈ (𝑡) = 𝑢𝑓̇ Γ (𝑡)

(Eq. 4-6)
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Similarly, the dynamic coupling equations are expressed as:
𝑇𝑓 (𝑡) + 𝑇𝑠 (𝑡) = 0

(Eq. 4-7)

where 𝑇 is the traction vector, that is defined as the product of the normalized
vector and stress tensor as follows:
𝑇 =𝜎∙𝑛

(Eq. 4-8)

To calculate the required fluid pressure needed for the valve as a function of
various PDMS elasticity and valve thicknesses, trendlines were added using three
different models as follows to find the best-fit equation to show the relationship between
water pressure, membrane thickness, and material elasticity (in the form of the mixing
ratio) to have a properly functioning valve:
Power model: 𝑦 = 𝑏𝑥 𝑚

(Eq. 4-9)

Exponential model: 𝑦 = 𝑏𝑚 𝑥

(Eq. 4-10)

Linear model: 𝑦 = 𝑚𝑥 + 𝑏

(Eq. 4-11)

6.2.3

Fabrication of cell co-culture microfluidic device

6.2.3.1

Device fabrication using replica molding
The cell co-culture device is fabricated using a replica molding technique from

the 3D printed carbon nanofiber molds and PDMS. Carbon nanofiber is given preference
over ABS, PLA, and nylon because of its low shrinkage factor that minimizes variability
in dimensions of the device components

243

. Three separate negative molds formed the

cell culture container, valve, and pressure chamber. After 3D printing (Creality3D Ender3 pro-High Precision 3D Printer), the surfaces are smoothened using sandpaper and
acetone. PDMS (Sylgard 184, Dow Corning, MI) is poured over the molds, treated in a
basic plasma cleaner (Harrick Plasma) for 10 minutes, and stored in a desiccator for 30
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minutes to eliminate bubble formation. The PDMS is allowed to solidify for 24 hours at
room temperature. Figure 6-3 shows an image of the fabricated device. Smoothing the
3D printed mold surfaces is a critical step to ensure the effective detachment of the
PDMS substrates. The components of the device are assembled in a direction from the
bottom to the top of the device using oxygen plasma treatment of the glass and PDMS.
The parts are treated for 3 minutes at low pressure (200 millitorrs) in the plasma chamber.
Using higher pressure leads to the deformation of the PDMS and reducing its capabilities
to bond to the other components of the device.

Figure 6-3: PDMS microfluidic cell co-culture device fabricated using replica
molding.241
6.2.3.2

Device fabrication using photolithography
The cell co-culture device fabricated using the photolithography technique

consists of two PDMS layers. The bottom layer includes the cell chambers, microfluidic
channel, inlets, and outlets, whereas the top PDMS layers involve a hydraulic pressure
chamber for regulating the valve movement to separate the two chambers. The mold for
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the first PDMS layer was fabricated using a negative photoresist (Hare SQ-5 and Hare
SQ-50) patterned by two transparent masks after positioning over a 4” silicon wafer
(Wafer World, FL). The masks were printed using a high-resolution printer from
Photomask portal, TX. The first transparent mask generated microchannels with
dimensions of 100 μm × 100 μm × 5 μm (length, width, and height). The second
transparent mask generated two cell culture chambers, wells for media reservoirs and
waste, and defined the connecting channels that allowed for media exchange between the
chambers (Figure 6-4 (A)). The dimensions of the cell chambers were 6 mm × 800 μm ×
100 μm (length, width, and height). A barrier was created between the cell chambers by
inserting a strip of PDMS 100 𝜇m wide having multiple connecting channels at the
bottom that could be opened or closed. The mold for the second PDMS layer was made
by attaching a slab of glass with dimensions of 4 mm × 12 mm × 1 mm (width, length,
and height) to a silicon wafer. A pre-polymer of PDMS was then mixed with a curing
agent at a 12:1 ratio and poured over the mold (Figure 6-4(B) and (C)). After degassing,
the PDMS layers were allowed to solidify over their molds at 70℃ for 2 h.
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Figure 6-4: Cell-co culture device fabricated by a photolithography technique using
PDMS. (A) Design of the chrome-plated photomask, (B) Pattern transferred
to silicon wafer after completion of the photolithography process, (C)
Solidified PDMS fabricated chips.
6.2.3.3

Device fabrication using stereolithography
The design of the cell culture device for the stereolithography method was

obtained using SolidWorks. The device consists of two parts: the bottom channel wall
that contains the cell culture chambers (1.3-inch × 0.40 inch × 600 μm each for length,
width, and height, respectively) and the inlets (0.40-inch diameter) and the top channel
wall that covers the bottom channel surface.
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Figure 6-5: Microfluidic cell co-culture device fabricated using stereolithography
method: (A) SolidWorks design for the top (yellow) and bottom (black)
channel walls, (B) & (C) Images of the fabricated lower channel wall of the
device with integrated supports to prevent bending.
Stereolithography 3D printing device (FormLabs) and clear resin bought from the
same vendor were used to fabricate the device. To avoid any bending of the device due to
its thin structure, full raft supports with a touchpoint of 0.50 mm were used. After the
printing was done, the device was thoroughly washed in isopropyl alcohol (IPA) and
dried at room temperature before placing it into the curing station. It is very important to
dry all portions of the device before curing as the wet parts would not be evenly cured as
the dry parts could leave the device sticky. After drying the IPA at room temperature, the
device was placed inside the curing station (FormLabs) for 45 minutes at 60℃ to solidify
the resin (Figure 6-5).
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6.3
6.3.1

Results and discussions

Valve displacement as a function of fluid pressure inside the pressure

chamber
The vertical displacement of the hydraulically controlled microfluidic valve is
modeled using COMSOL Multiphysics 5.4. The physics-controlled extremely fine mesh
was chosen for the device under study. COMSOL uses physics (structural mechanics of
materials) to optimize the mesh size. Specifically, the mesh was finer in areas that are
prone to stress concentrations (e.g., the attachment points of the membrane to the rest of
the device). The model uses the value of the stiffness factor of PDMS (also known as the
Young’s Modulus) and the density of the valve material from two previously published
articles that depend on the various crosslinking ratio of the PDMS base and the curing
agent 244,245. Initially, a standard 10:1 crosslinker ratio is employed to analyze the impact
of fluid pressure (15 mm-H2O, 20 mm-H2O, 25 mm-H2O, 30 mm-H2O, 35 mm-H2O, 40
mm-H2O, and 45 mm-H2O) and valve thicknesses (0.1 mm to 1 mm) on the valve
displacement. The model shows that the displacement of the valve is directly proportional
to the fluid pressure and inversely proportional to the valve thickness (Figure 6-6).
Numerical simulations show that valve thickness of 0.1 mm provides the maximum
deflection while 1 mm accounts for the lowest. Results indicate a change in vertical
displacement from 0.025 mm to 0.886 mm for valve thicknesses of 1 mm and 0.1 mm,
respectively, using a 15 mm constant fluid pressure (15 mm-H2O).
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Figure 6-6: Valve displacement in the vertical direction as a function of (a) pressure
exerted by the fluid inside the pressure chamber, and (b) thickness of the
valve. Simulations were performed for the 10:1 elastomer base to crosslinker
ratio.241
The dimensions of the pressure chamber have a significant impact on the
deflection of the valve. Increasing the height of the hydraulic chamber from 15 mm to
45mm exerts more force on the valve due to additional fluid pressure (mm-H2O) which
increases the deflection of the 1 mm thick valve by 208%. This impact is 168% and 34%
for valve thicknesses of 0.5 mm and 0.1 mm, respectively. This is a very important factor
for the efficient design of the cell co-culture device as it ensures permanent isolation of
the cell chambers. While thick PDMS valves require a significant amount of initial
hydraulic pressure to actuate, thin valves require lower fluid pressure to actuate the valve
displacement. For the same hydraulic pressure, the thick valves account for lower
displacements compared to the thinner valves (Figure 6-6b).

115
6.3.2

Valve displacement as a function of valve thickness and PDMS elasticity
Mathematical simulations indicate that the vertical displacement increases by 0.25

mm when the valve thickness is changed from 1 mm to 0.1 mm for 45 mm-H2O fluid
pressure. The change in valve deflection is 0.16 mm when the fluid pressure inside the
hydraulic pressure chamber decrease to 30 mm-H2O. PDMS with different crosslinking
ratios was modeled to determine its effect on the displacement of the valve (Figure 6-7).

Figure 6-7: Pressure (mm-H2O) required for 0.5mm valve deflection as a function of
valve thicknesses and PDMS elasticity.241
6.3.3

Valve deflection as a function of various PDMS base and curing agent

crosslinking ratio
Figure 6-8 represents the deflection profiles of various elastomer base and
crosslinking ratios (10:1, 20:1, 40:1, and 50:1) that correspond to the moduli of elasticity
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of 2060.6 kPa, 1163.75 kPa, 715.33 kPa, and 625.64 kPa, respectively 244. The analysis
was performed using a 0.5 mm thick valve and 30 mm-H2O.

Figure 6-8: Simulation of the effect of PDMS elasticity in valve defections. Analyses
were performed for a device that has a 30 mm pressure chamber height, 0.5
mm thick valve, and 10:1, 20:1, 40:1, and 50:1 crosslinking ratio of PDMS
base and curing agent.241
Mathematical simulations show that the deflection of the valve increases by 58%
for a change in PDMS crosslinking ratio from 10:1 to 20:1. Moreover, the increase
becomes 143% when the elasticity is increased to 50:1. Polymer with standard elasticity
(10:1) is normally used for the fabrication of PDMS microfluidic devices. Optimal
deflection of the valve by minimizing the required pressure can be obtained by improving
the elasticity of the valve using higher concentrations of the PDMS. The distance
between the hydraulic valve and the lower channel wall of the device is 0.5 mm.
Therefore, the optimal design parameters ensure that the valve deflects 0.5 mm in a
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vertical position. The pressure required to cause a 0.5 mm deflection of the valve for
varying valve thicknesses and elasticity is presented in Table 6-1.
Table 6-1: Fluid pressure (mm-H2O) required to deflect the valve 0.5 mm for
various thicknesses and PDMS base to curing agent crosslinking ratio.

Pressure chamber height (mm)
Valve
thickness
(mm)
PDMS
5:1

PDMS
10:1

PDMS
20:1

PDMS
30:1

PDMS
40:1

PDMS
50:1

0.1

4.07

1.75

0.73

0.44

0.32

0.25

0.2

13.89

5.85

2.26

1.29

0.88

0.67

0.3

36.82

19.95

9.68

6.12

4.41

3.44

0.4

66.94

39.88

23.43

16.92

13.38

11.19

0.5

107.9

63.91

39.51

30.28

25.27

22.07

0.6

160.72

94.17

58.32

45.29

38.45

34.14

0.7

221.4

128.44

79.57

62.02

53.04

47.29

0.8

291.16

170.48

105.33

81.38

69.44

61.92

0.9

382.38

212.31

134.21

103.17

87.44

78.20

1

453.6

264.88

164.51

125.79

107.28

95.49
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Prior publications have shown that PDMS permeability depends on its thickness
246

. However, for our application, this factor was irrelevant and was not considered a

critical parameter. During the actual experimental studies, the device will be set up in the
cell culture chamber at 37°C, with 5% CO2 that will diffuse freely into the chambers
through the cell culture wells.
6.3.4

Statistical analysis
Statistical testing is performed to develop an equation to predict the necessary

pressure to deflect the membrane 0.5 mm for various membrane thicknesses and PDMS
base-crosslinker ratios. From the analysis, the equation in the form of a product of
exponential functions was created:
𝑦 = 𝑏 (𝑚1 )𝑥1 (𝑚2 )𝑥2

(Eq. 4-12)

where 𝑦 represents the pressure needed (in mm-H2O), 𝑥1 represents the thickness of
the membrane (in mm), and 𝑥2 represents the PDMS base-crosslinker ratio (in the form
of x:1). The analysis to determine the best-fit curve for the data collected yields the
following constant values: 𝑏 = 3.326, 𝑚1 = 302.3, and 𝑚2 = 0.9603. The standard
error for the three constants 𝑏, 𝑚1 , and 𝑚2 are 0.2316, 0.2984, and 0.005384,
respectively. Comparing t-observed values for each of the three constants to the critical
value (2.002) shows that all three constants are needed in approximating the necessary
pressure to close the valve. The coefficient of determination for the equation developed
is 0.8812. To determine the best-fit equation, linear and power models were also
implemented. It was determined that the exponential equation had the highest
correlation of determination (0.881) compared to the linear (0.697) and the power
(0.747) equations. Therefore, the choice of the exponential model is justified.
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A surface plot with the values of the design parameters is presented in Figure 6-9. The
dimensions of the microfluidic device are within the limits of the replica molding
technique, and the valve design requires that it is deflected under minimal pressure.
Therefore, the optimal design parameters will ensure minimal pressure chamber height
and maximum valve thickness that provide the most efficient displacement.

Figure 6-9: Surface plot of the values of the fluid pressure (mm-H2O), valve thickness,
and PDMS elasticity ratio that ensures 0.5 mm displacement of the valve.241
6.4

Conclusion

This study presents the design and fabrication of a microfluidic cell co-culture
device with a hydraulically controlled PDMS valve for the reversible isolation of two
distinct cell-culture chambers. A two-dimensional numerical model identifies the optimal
design parameters, including valve thickness and pressure exerted by the fluid inside the
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hydraulic pressure chamber that enables valve actuation. The reported device has a new
design and is easy to fabricate. Future work will focus on the implementation of this
device in cell co-culture study.
.

CONCLUSIONS AND RECOMMENDATIONS
Findings from each study are described at the end of the corresponding chapter.
The overall conclusions and suggestions for future work are presented in this chapter.
7.1

Conclusions

Chapter 2 provides an overview of the existing exosome isolation and detection
methods, their efficiencies and drawbacks, the importance of microfluidics for exosome
study, and finally a detailed summary of the most recent microfluidic platforms for the
separation and detection of exosomes from various biofluids. Although much progress
has been achieved in recent years with on-chip exosome isolation and detection, there is
still room for improvements to utilize these techniques in clinical and research settings.
Exosomes encapsulate genomic and proteomic biomarkers for non-invasive
diagnosis and disease monitoring. However, exosome surface-markers heterogeneity is a
major drawback of current isolation methods. In chapter 3, the approach for the
functionalization of the ExoPRIME tool (300μm×30mm) with the polyelectrolytes,
biotin, streptavidin, and anti-CD63 antibodies has been presented. FESEM and EDX
analyses were performed to confirm the layer-by-layer assembly of the polyelectrolytes
on the microprobe surfaces. Additionally, confirmation of the anti-CD63 immobilization
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was obtained using fluorescence imaging by immobilizing the streptavidin-coated
microneedles in the biotinylated FITC solution.
The lab-on-a-chip thermoelectric immunosensor presented in chapter 4 was able
to quantify the inflammatory cytokine, TNF-α, with picomolar sensitivity. The feasibility
of the technology was demonstrated via accurate measurement of the concentration of
TNF-α in astrocytes cell culture media. The immunoassay was performed in a
microfluidic device with an integrated antimony-bismuth thermopile sensor and had a
limit of detection of 14 pg mL-1. The device was fabricated using the rapid prototyping
xurography technique and consisted of two inlets and a single outlet. The anti-TNF-α
monoclonal antibody was used to capture the analyte while the detection was performed
using glucose oxidase-conjugated secondary antibody. A standard calibration curve was
created using serial dilutions of synthetic TNF-α (0 –2000 pg mL-1) by plotting the area
under the curve of the signal versus the concentration of the analyte. The efficacy of the
device was evaluated by quantifying TNF-α in the cell culture medium of
lipopolysaccharide-stimulated and non-stimulated astrocytes. The results demonstrated
the excellent accuracy of the calorimetric immunoassay when compared with a standard
commercial ELISA microplate reader. The immunosensor offers high reproducibility and
versatility in the choice of the detection enzyme.
Chapter 5 reports a three-dimensional numerical analysis of the critical design
parameters of a continuous-flow biosensor with an integrated thermopile to significantly
increase the detection sensitivity of the platform. The work discusses the impact of
volumetric flow rate, channel height, material thermal properties, and heat sink on the
magnitude of the thermoelectric signal. Since this experimental configuration has been
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implemented in a variety of biochemical analyses, particular emphasis in this work is
maximizing the detection sensitivity of the device. Computational thermal modeling was
performed to investigate the impact of channel height (50 µm, 100 µm, 150 µm, and 200
µm), the volumetric flow rate of the substrate (25µL min-1 and 50µL min-1), and the
microdevice material (glass, PMMA, and PDMS) on the output of the thermoelectric
sensor. Experimental data validated the model and provided an excellent correlation
between the predicted and measured voltage output. Results show that fabricating the
calorimeter out of materials with lower thermal diffusivity, reducing the channel height,
and eliminating the heat sink at the reference junction of the thermopile increases the
sensitivity of the platform by 783%.
The design, fabrication, and a two-dimensional numerical analysis to identify the
optimal operating parameters of a novel microfluidic co-culture platform with an
integrated pressure-controlled valve are presented in chapter 6. Photolithography,
stereolithography, and replica molding using 3D printed PDMS molds were used for the
fabrication of three different cell co-culture devices. Altering the position of the PDMS
hydraulic valve permits individual manipulation of the cellular microenvironment of the
two adjacent cell culture chambers. The mathematical model analyzes the deflection
profile of the valve in the vertical direction as a function of several parameters: valve
thicknesses, the pressure exerted by the fluid inside the pressure chamber, and PDMS
elasticity determined by the ratio of the elastomer base and the curing reagent. The valve
understudy requires a deflection of 0.5 mm to completely isolate the two cell chambers.
The combination of the optimal design parameters is identified using numerical analysis.
Mathematical simulations show that the deflection of the membrane is inversely
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proportional to the valve membrane thickness and directly proportional to the pressure
exerted by the fluid on the valve.
7.2

Future Work

Fabrication of lab-on-a-chip calorimetric immunosensors using PDMS as both the
upper and lower channel walls could increase the LOD of the thermoelectric platform as
indicated by the numerical analysis. Therefore, future work should focus on the
fabrication and implementation of PDMS-PDMS (upper and lower walls respectively)
microfluidic calorimetric immunoassay and compare the results with the presented
numerical model in this dissertation.
While this work was focused on the design and fabrication of a microfluidics cell
co-culture platform, future work should focus on the integration of two cell lines within
the device. The effective manipulation of the microenvironments will provide insights
into cellular behavior, as well as the change that occurs at the genomic and transcriptomic
levels.
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APPENDIX
Figure A 1: Temperature distribution profile at the outer surface of the lower channel
wall 0, 60, and 240 seconds after the introduction of the substrate. The
channel height is 50μm and the upper and lower channel walls are fabricated
from glass. (i) Reference junctions not in contact with a heat sink; (ii)
reference junctions in contact with the aluminum heat sink.
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Table A 1: Area under the curve (μV-s) of thermoelectric response (0-2000 pg mL-1
TNF-α) that were used to create the standard calibration curve.
0 pg mL-1

125 pg mL-1

250 pg mL-1

1000 pg mL-1 2000 pg mL-1

Injection 1

0.41

8.54

10.64

35.7

66.7

Injection 2

0.15

8.69

10.20

35.8

62.3

Injection 3

0.45

7.06

10.58

38.4

67.9

Injection 4

0.34

6.97

10.67

36.2

59.7

Average
AUC

0.34

7.81

10.47

35.52

64.15

Standard
error

0.07

0.46

0.10

0.63

1.91
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Table A 2: Inter and intra-calorimetric assay variation for devices with 250 pg mL-1
TNF-𝛼.
# of injections

Area Under the Curve (AUC)
Device 1

Device 2

Device 3

Injection 1

10.64

10.41

10.33

Injection 2

10.58

10.39

10.38

Injection 3

10.49

10.44

10.42

Average AUC (𝜇Vs)

10.57

10.41

10.38

Standard deviation

0.08

0.03

0.05

% Coefficient of
variation

0.72 %

0.24 %

0.47 %

Inter-assay Average
AUC (𝜇V-s)
Inter-assay standard
deviation
Inter-assay %
coefficient of
variation

10.45

0.10

0.99 %
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Table A 3: Global parameters defined for the mathematical model
Parameters

Values

𝐷𝑔 = Diffusion coefficient of glucose

6.7×10-10 m2s-1 210

𝑐𝑖 ≡ Glucose concentration

55 mol m-3

𝑐𝐺𝑜𝑥 ≡ Glucose oxidase concentration

6.9892×10-4 mol m-3

𝑢𝑤 ≡ Inlet 1 velocity

0.000674 m s-1

𝑢𝑔 ≡ Inlet 2 velocity

0.000168 m s-1 and 0.000084 m s-1

𝑡𝑢 ≡ Upper channel wall thickness

1 mm

𝑡𝑏 ≡ Lower channel wall thickness

170 μm

𝐿𝑐 ≡ Channel length

65 mm

𝑊𝑐 ≡ Channel width

12 mm

𝑡𝑐 ≡ Channel height

25 μm, 50 μm, 100 μm, 200 μm

𝐿𝑠 ≡ Thermopile sensor length

8 mm

𝑊𝑠 ≡ Thermopile sensor width

8 mm

𝑡𝑠 ≡ Thermopile sensor thickness

100 μm

𝐿𝑟 ≡ Reaction zone length

8 mm

𝑊𝑟 ≡ Reaction zone width

3 mm

ℎ𝑟 ≡ Reaction zone height

10 μm

𝐿𝐷 ≡ Device length

75 mm

𝑊𝑑 ≡ Device width

25 mm

𝐻𝑑 ≡ Device height

1270 μm

𝑘𝑔 ≡ Reaction rate constant

3×104 L mol-1 s-1

211
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Table A 4: Parameters used to define the governing equations of the mathematical
model.
Nomenclature
Cp Specific heat at constant pressure (kJ

ΔE Change in internal energy (J kg-1)

kg-1 °C

q

k Thermal conductivity W m-1 °C-1

cGox Concentration of glucose oxidase

um Mass velocity (kg m−2 s −1 )

(mol m-3)

L

Eg Enzymatic reaction energy (J mol-1)

Channel length (m)

Conductive heat flux vector

U Velocity vector

µ Viscosity (kg m-1 s-1)

UT Transpose of the velocity vector

ρ

p

σ Total stress tensor

Pressure (Pa)

Density (kg m-3)

x X-axis location

τ

Viscous stress tensor

y Y-axis location

β

Coefficient of thermal expansion (K-1)

z

Z-axis location

α

Seebeck coefficient (µV mK-1)

h

Enthalpy (J)

u

Velocity magnitude (ms-1)

Subscript

cg Concentration of glucose (mol m−3)

f

Fluid

kg Reaction rate constant (mol m−3 s)

g

Glucose

Dg Diffusion coefficient of glucose (m2 s-1)
Fb Body force (N)
uin Inlet velocity (ms-1)
T Temperature (K)
ΔV Voltage difference (µV)
Q

Heat rate (W m-3)
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Table A 5: Material properties of water, glass, PDMS, and PMMA obtained from the
COMSOL library.
Material property

Water

Glass

PMMA

PDMS

Density (kg m-3)

997

2203

1190

970

Specific heat
capacity (J kg-1 K-1)

4182

703

1420

1460

Thermal
conductivity

0.6

1.38

0.19

0.16

(W m-1K-1)
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